cervical cancer - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

RGD DISEASE ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:	cervical cancer	go back to main search page
Accession:	DOID:4362	browse the term
Definition:	A female reproductive organ cancer that is located_in the cervix. (DO)
Synonyms:	exact_synonym:	cancer of cervix; cancer of the cervix; cancer of the uterine cervix; cervix cancer; cervix cancers; cervix uteri cancer; uterine cervical cancer; uterine cervical cancers
	xref:	ICD10CM:C53; ICD9CM:180; MONDO:0002974; NCI:C2940; NCI:C9311
For additional species annotation, visit the Alliance of Genome Resources.

Please select species to view GViewer data.

show annotations for term's descendants Sort by:
Rat (98) Mouse (105) Human (161) Chinchilla (87) Bonobo (92) Dog (92) Squirrel (87) Pig (92) Green Monkey (91) Naked Mole-rat (86) All
Genes (924) Variants (13) Cell Lines (54)

cervical cancer

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

G

angiogenin

protein:increased expression:serum

NCBI chr29:21,215,985...21,226,927

G

P

angiogenin

protein:increased expression:serum

NCBI chr 7:78,249,479...78,262,846
Ensembl chr 7:78,249,487...78,250,138

G

S

angiogenin

protein:increased expression:serum

NCBI chrNW_004936880:39,372...40,070

G

B

angiogenin

protein:increased expression:serum

NCBI chr14:1,548,693...1,558,528
Ensembl chr14:19,614,950...19,615,393

G

R

angiogenin

protein:increased expression:serum

RGD

NCBI chr15:24,312,711...24,323,361

G

M

angiogenin, ribonuclease, RNase A family, 5

protein:increased expression:serum

RGD

NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466

G

H

angiogenin

protein:increased expression:serum

RGD

NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971

G

N

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

PMID:18503157 PMID:19292061

RGD:2315657 RGD:2315662

NCBI chrNW_004624825:4,711,921...4,714,926
Ensembl chrNW_004624825:4,708,093...4,714,921

G

G

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

PMID:18503157 PMID:19292061

RGD:2315657 RGD:2315662

NCBI chr29:20,978,878...20,981,393

G

P

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

PMID:18503157 PMID:19292061

RGD:2315657 RGD:2315662

NCBI chr 7:78,451,845...78,454,938
Ensembl chr 7:78,451,851...78,454,938

G

S

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

PMID:18503157 PMID:19292061

RGD:2315657 RGD:2315662

NCBI chrNW_004936877:666,545...669,351
Ensembl chrNW_004936877:666,523...669,338

G

D

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

PMID:18503157 PMID:19292061

RGD:2315657 RGD:2315662

NCBI chr15:17,786,808...17,789,422
Ensembl chr15:17,786,357...17,789,422

G

B

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

PMID:18503157 PMID:19292061

RGD:2315657 RGD:2315662

NCBI chr14:1,329,745...1,332,315
Ensembl chr14:19,381,911...19,384,542

G

C

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

PMID:18503157 PMID:19292061

RGD:2315657 RGD:2315662

NCBI chrNW_004955550:1,273,170...1,275,843
Ensembl chrNW_004955550:1,273,284...1,279,743

G

R

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

RGD

PMID:19292061 PMID:18503157

RGD:2315657, RGD:2315662

NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785

G

M

apurinic/apyrimidinic endonuclease 1

DNA:polymorphism: :p.D148E (human)

RGD

PMID:19292061 PMID:18503157

RGD:2315657, RGD:2315662

NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596

G

H

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:polymorphism: :p.D148E (human)

RGD

PMID:19292061 PMID:18503157

RGD:2315657, RGD:2315662

NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772

G

N

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

NCBI chrNW_004624767:4,591,562...4,614,365

G

G

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

NCBI chr 1:22,029,723...22,064,553
Ensembl chr 1:22,034,317...22,064,541

G

P

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

NCBI chr 2:18,962,262...18,994,235
Ensembl chr 2:18,962,270...18,994,240

G

S

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

NCBI chrNW_004936562:5,229,157...5,253,175
Ensembl chrNW_004936562:5,229,174...5,253,181

G

D

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

NCBI chr18:26,326,387...26,355,580
Ensembl chr18:26,327,920...26,355,585

G

B

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

NCBI chr11:43,279,024...43,311,602
Ensembl chr11:43,759,414...43,791,975

G

C

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

NCBI chrNW_004955422:4,121,913...4,149,242
Ensembl chrNW_004955422:4,121,837...4,149,471

G

R

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

RGD

NCBI chr 3:80,378,096...80,403,259
Ensembl chr 3:80,378,096...80,403,264

G

M

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

RGD

NCBI chr 2:94,242,073...94,268,490
Ensembl chr 2:94,242,027...94,268,481

G

H

apoptosis inhibitor 5

disease_progression

mRNA:increased expression

RGD

NCBI chr11:43,311,996...43,344,529
Ensembl chr11:43,311,963...43,344,529

G

N

BCL2 like 1

protein:increased expression:uterine cervix

NCBI chrNW_004624741:788,445...838,513
Ensembl chrNW_004624741:789,355...839,507

G

G

BCL2 like 1

protein:increased expression:uterine cervix

NCBI chr 2:36,059,024...36,118,332
Ensembl chr 2:36,058,919...36,116,470

G

P

BCL2 like 1

protein:increased expression:uterine cervix

NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694

G

S

BCL2 like 1

protein:increased expression:uterine cervix

NCBI chrNW_004936485:18,654,046...18,707,324

G

D

BCL2 like 1

protein:increased expression:uterine cervix

NCBI chr24:21,145,214...21,209,425
Ensembl chr24:21,145,215...21,196,355

G

B

BCL2 like 1

protein:increased expression:uterine cervix

NCBI chr20:27,955,688...28,015,950
Ensembl chr20:29,088,055...29,146,585

G

C

BCL2 like 1

protein:increased expression:uterine cervix

NCBI chrNW_004955422:29,254,440...29,307,104
Ensembl chrNW_004955422:29,254,216...29,308,174

G

R

Bcl2-like 1

protein:increased expression:uterine cervix

RGD

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479

G

M

BCL2-like 1

protein:increased expression:uterine cervix

RGD

NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648

G

H

BCL2 like 1

protein:increased expression:uterine cervix

RGD

NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989

G

N

baculoviral IAP repeat containing 2

mRNA:decreased expression:uterine cervix

NCBI chrNW_004624878:476,460...514,637

G

G

baculoviral IAP repeat containing 2

mRNA:decreased expression:uterine cervix

NCBI chr 1:93,721,449...93,746,638

G

S

baculoviral IAP repeat containing 2

mRNA:decreased expression:uterine cervix

NCBI chrNW_004936551:5,515,904...5,535,864

G

D

baculoviral IAP repeat containing 2

mRNA:decreased expression:uterine cervix

NCBI chr 5:29,294,080...29,314,837
Ensembl chr 5:29,294,692...29,312,771

G

B

baculoviral IAP repeat containing 2

mRNA:decreased expression:uterine cervix

NCBI chr11:97,298,736...97,324,966
Ensembl chr11:100,793,036...100,822,421

G

C

baculoviral IAP repeat containing 2

mRNA:decreased expression:uterine cervix

NCBI chrNW_004955412:5,658,322...5,685,628
Ensembl chrNW_004955412:5,659,478...5,685,114

G

R

baculoviral IAP repeat-containing 2

mRNA:decreased expression:uterine cervix

RGD

NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732

G

M

baculoviral IAP repeat-containing 2

mRNA:decreased expression:uterine cervix

RGD

NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065

G

H

baculoviral IAP repeat containing 2

mRNA:decreased expression:uterine cervix

RGD

NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670

G

N

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

NCBI chrNW_004624795:1,186,043...1,238,986
Ensembl chrNW_004624795:1,188,136...1,241,964

G

G

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

NCBI chr16:63,162,827...63,243,928

G

P

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

NCBI chr12:19,788,087...19,854,515
Ensembl chr12:19,786,020...19,854,668

G

S

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

NCBI chrNW_004936490:17,735,444...17,801,456

G

D

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

NCBI chr 9:19,958,941...20,025,494
Ensembl chr 9:19,958,391...20,025,494

G

B

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

NCBI chr17:14,197,946...14,279,064
Ensembl chr17:14,428,526...14,506,815

G

C

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

NCBI chrNW_004955451:16,819,463...16,870,780
Ensembl chrNW_004955451:16,819,023...16,855,528

G

R

BRCA1, DNA repair associated

disease_progression

DNA:hypermethylation:promoter

RGD

NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304

G

M

breast cancer 1, early onset

disease_progression

DNA:hypermethylation:promoter

RGD

NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781

G

H

BRCA1 DNA repair associated

disease_progression

DNA:hypermethylation:promoter

RGD

NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245

G

N

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chrNW_004624871:2,051,044...2,195,364
Ensembl chrNW_004624871:2,052,863...2,198,165

G

G

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chr16:32,909,226...33,085,551
Ensembl chr16:32,910,693...33,082,587

G

P

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chr12:36,498,138...36,639,847
Ensembl chr12:36,498,205...36,635,973

G

S

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chrNW_004936490:3,001,445...3,139,538
Ensembl chrNW_004936490:3,003,484...3,137,479

G

D

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chr 9:34,804,285...34,984,640
Ensembl chr 9:34,806,535...34,983,788

G

B

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chr17:55,786,568...55,973,366
Ensembl chr17:60,901,073...61,083,462

G

C

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chrNW_004955451:2,705,834...2,820,610
Ensembl chrNW_004955451:2,707,793...2,818,592

G

R

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324

G

M

BRCA1 interacting protein C-terminal helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chr11:85,948,957...86,092,041
Ensembl chr11:85,948,964...86,092,019

G

H

BRCA1 interacting helicase 1

ClinVar Annotator: match by term: Cervical cancer

PMID:18483852 PMID:25741868 PMID:26467025 PMID:26790966 PMID:28492532 More...

NCBI chr17:61,679,139...61,863,528
Ensembl chr17:61,679,139...61,863,559

G

N

basigin (Ok blood group)

disease_progression

NCBI chrNW_004624828:7,913,297...7,920,891
Ensembl chrNW_004624828:7,913,099...7,920,804

G

G

basigin (Ok blood group)

disease_progression

NCBI chr 6:309,579...320,209
Ensembl chr 6:309,506...321,785

G

P

basigin

disease_progression

NCBI chr 2:77,735,586...77,743,451

G

S

basigin (Ok blood group)

disease_progression

NCBI chrNW_004936588:181,688...189,795
Ensembl chrNW_004936588:181,576...189,287

G

D

basigin

disease_progression

NCBI chr20:57,942,703...57,951,089
Ensembl chr20:57,943,276...57,951,061

G

B

basigin (Ok blood group)

disease_progression

Ensembl chr19:539,815...551,456

G

C

basigin (Ok blood group)

disease_progression

NCBI chrNW_004955495:7,148,806...7,156,296

G

R

basigin (Ok blood group)

disease_progression

RGD

NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387

G

M

basigin

disease_progression

RGD

NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803

G

H

basigin (Ok blood group)

disease_progression

RGD

NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494

G

G

caspase 3

NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899

G

P

caspase 3

NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213

G

S

caspase 3

NCBI chrNW_004936554:4,571,072...4,593,765

G

D

caspase 3

NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505

G

B

caspase 3

NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185

G

C

caspase 3

NCBI chrNW_004955403:24,315,712...24,326,271

G

R

caspase 3

RGD

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

M

caspase 3

RGD

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

H

caspase 3

RGD

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

G

cyclin B1

mRNA, protein:increased expression:uterine cervix

NCBI chr 4:65,265,798...65,276,465
Ensembl chr 4:65,265,844...65,277,085

G

P

cyclin B1

mRNA, protein:increased expression:uterine cervix

NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377

G

S

cyclin B1

mRNA, protein:increased expression:uterine cervix

NCBI chrNW_004936480:400,287...407,677
Ensembl chrNW_004936480:399,224...407,704

G

D

cyclin B1

mRNA, protein:increased expression:uterine cervix

NCBI chr 2:54,256,957...54,264,749

G

B

cyclin B1

mRNA, protein:increased expression:uterine cervix

NCBI chr 5:44,826,103...44,836,832
Ensembl chr 5:46,394,362...46,405,332

G

C

cyclin B1

mRNA, protein:increased expression:uterine cervix

NCBI chrNW_004955446:140,661...149,500
Ensembl chrNW_004955446:140,093...149,500

G

R

cyclin B1

mRNA, protein:increased expression:uterine cervix

RGD

NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172

G

M

cyclin B1

mRNA, protein:increased expression:uterine cervix

RGD

NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078

G

H

cyclin B1

mRNA, protein:increased expression:uterine cervix

RGD

NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245

G

N

CD55 molecule (Cromer blood group)

NCBI chrNW_004624807:4,252,676...4,274,828

G

G

CD55 molecule (Cromer blood group)

NCBI chr25:22,055,138...22,092,472
Ensembl chr25:22,073,629...22,092,173

G

P

CD55 molecule (Cromer blood group)

NCBI chr 9:67,933,069...67,960,380

G

S

CD55 molecule (Cromer blood group)

NCBI chrNW_004936557:5,344,373...5,364,234

G

D

CD55 molecule

NCBI chr 7:6,361,037...6,396,063
Ensembl chr 7:6,360,964...6,386,226

G

B

CD55 molecule (Cromer blood group)

NCBI chr 1:182,923,369...182,962,518
Ensembl chr 1:187,201,081...187,240,350

G

C

CD55 molecule (Cromer blood group)

NCBI chrNW_004955406:42,773,368...42,796,205

G

R

CD55 molecule (Cromer blood group)

RGD

NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831

G

M

CD55 molecule, decay accelerating factor for complement

RGD

NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481

G

H

CD55 molecule (Cromer blood group)

RGD

NCBI chr 1:207,321,678...207,360,966
Ensembl chr 1:207,321,519...207,386,804

G

N

cell division cycle 25A

NCBI chrNW_004624730:73,443,895...73,463,979
Ensembl chrNW_004624730:73,443,731...73,464,486

G

G

cell division cycle 25A

NCBI chr22:9,534,114...9,564,927
Ensembl chr22:9,534,053...9,564,741

G

P

cell division cycle 25A

G

S

cell division cycle 25A

NCBI chrNW_004936596:1,657,411...1,680,109
Ensembl chrNW_004936596:1,659,159...1,678,788

G

D

cell division cycle 25A

NCBI chr20:40,823,683...40,849,113
Ensembl chr20:40,823,459...40,847,608

G

B

cell division cycle 25A

NCBI chr 3:48,068,601...48,099,806
Ensembl chr 3:49,154,307...49,186,115

G

C

cell division cycle 25A

NCBI chrNW_004955420:24,345,002...24,361,802
Ensembl chrNW_004955420:24,344,388...24,362,596

G

R

cell division cycle 25A

RGD

NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701

G

M

cell division cycle 25A

RGD

NCBI chr 9:109,704,545...109,722,963
Ensembl chr 9:109,704,647...109,722,963

G

H

cell division cycle 25A

RGD

NCBI chr 3:48,157,146...48,188,417
Ensembl chr 3:48,157,146...48,188,417

G

N

cell division cycle 25C

NCBI chrNW_004624743:31,099,320...31,123,808
Ensembl chrNW_004624743:31,099,268...31,124,262

G

G

cell division cycle 25C

NCBI chr23:40,960,154...41,013,016
Ensembl chr23:40,960,572...41,006,984

G

P

cell division cycle 25C

NCBI chr 2:140,289,156...140,323,696
Ensembl chr 2:140,289,115...140,324,425

G

S

cell division cycle 25C

NCBI chrNW_004936531:7,471,722...7,499,781
Ensembl chrNW_004936531:7,471,722...7,499,766

G

D

cell division cycle 25C

NCBI chr11:25,904,152...25,940,754
Ensembl chr11:25,904,144...25,935,744

G

B

cell division cycle 25C

NCBI chr 5:133,663,210...133,717,974
Ensembl chr 5:139,795,565...139,842,698

G

C

cell division cycle 25C

NCBI chrNW_004955418:2,114,053...2,138,513

G

R

cell division cycle 25C

RGD

NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185

G

M

cell division cycle 25C

RGD

NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586

G

H

cell division cycle 25C

RGD

NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355

G

N

cadherin 13

DNA:hypermethylation:promoter

NCBI chrNW_004624746:3,696,608...4,759,693
Ensembl chrNW_004624746:3,698,196...4,759,442

G

G

cadherin 13

DNA:hypermethylation:promoter

NCBI chr 5:68,048,655...69,213,102
Ensembl chr 5:68,451,894...69,211,534

G

P

cadherin 13

DNA:hypermethylation:promoter

NCBI chr 6:4,809,752...5,832,188
Ensembl chr 6:4,808,255...5,832,415

G

S

cadherin 13

DNA:hypermethylation:promoter

NCBI chrNW_004936641:3,925,185...4,223,421
Ensembl chrNW_004936641:3,931,033...4,224,101

G

D

cadherin 13

DNA:hypermethylation:promoter

NCBI chr 5:68,491,156...69,586,119
Ensembl chr 5:68,492,022...69,489,255

G

B

cadherin 13

DNA:hypermethylation:promoter

NCBI chr16:63,255,482...64,418,053
Ensembl chr16:82,883,184...83,808,996

G

C

cadherin 13

DNA:hypermethylation:promoter

NCBI chrNW_004955564:407,120...1,549,880
Ensembl chrNW_004955564:408,730...1,426,841

G

R

cadherin 13

DNA:hypermethylation:promoter

RGD

NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459

G

M

cadherin 13

DNA:hypermethylation:promoter

RGD

NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660

G

H

cadherin 13

DNA:hypermethylation:promoter

RGD

NCBI chr16:82,626,969...83,800,640
Ensembl chr16:82,626,965...83,800,640

G

N

cyclin dependent kinase 1

NCBI chrNW_004624791:2,891,239...2,915,001

G

G

cyclin dependent kinase 1

NCBI chr 9:70,475,736...70,492,947

G

P

cyclin dependent kinase 1

NCBI chr14:64,233,945...64,255,290
Ensembl chr14:64,233,987...64,372,197

G

S

cyclin dependent kinase 1

NCBI chrNW_004936614:2,300,682...2,313,611
Ensembl chrNW_004936614:2,300,513...2,313,624

G

D

cyclin dependent kinase 1

NCBI chr 4:12,884,106...12,899,203
Ensembl chr 4:12,883,385...12,899,197

G

B

cyclin dependent kinase 1

NCBI chr10:57,314,692...57,331,261
Ensembl chr10:59,647,993...59,664,434

G

C

cyclin dependent kinase 1

NCBI chrNW_004955425:14,210,681...14,226,474
Ensembl chrNW_004955425:14,210,680...14,226,474

G

R

cyclin-dependent kinase 1

RGD

NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408

G

M

cyclin dependent kinase 1

RGD

NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768

G

H

cyclin dependent kinase 1

RGD

NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852

G

D

major histocompatibility complex, class II, DQ beta 1

susceptibility

DNA:polymorphisms::HLA-DQB1*050201, DQB1*060101, DQB1*0602(human)
associated with Papillomavirus Infections;DNA:polymorphism: :HLA-DQB1 G > A (rs6457617)(human)

PMID:16425277 PMID:25893807

RGD:36174015 RGD:36174023

NCBI chr12:2,305,307...2,307,711

G

D

MHC class I DLA-88

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-B7

NCBI chr12:892,442...895,691
Ensembl chr12:892,388...1,021,690

G

N

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

NCBI chrNW_004624763:8,621,666...8,649,109
Ensembl chrNW_004624763:8,621,638...8,650,016

G

G

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

NCBI chr 8:104,240,197...104,266,768
Ensembl chr 8:104,251,418...104,264,703

G

P

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

NCBI chr 4:27,986,270...28,013,970
Ensembl chr 4:27,986,866...28,013,945

G

S

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

NCBI chrNW_004936470:35,449,920...35,473,635
Ensembl chrNW_004936470:35,450,292...35,473,110

G

D

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

NCBI chr13:10,081,700...10,099,737
Ensembl chr13:10,081,695...10,099,501

G

B

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

NCBI chr 8:106,190,208...106,216,402
Ensembl chr 8:108,335,590...108,361,475

G

C

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

NCBI chrNW_004955417:16,941,035...16,958,876
Ensembl chrNW_004955417:16,936,622...16,958,876

G

R

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

RGD

NCBI chr 7:75,810,950...75,828,902
Ensembl chr 7:75,810,594...75,861,248

G

M

estrogen receptor-binding fragment-associated gene 9

disease_progression

protein:increased expression:uterine cervix

RGD

NCBI chr15:44,482,574...44,504,916
Ensembl chr15:44,482,571...44,504,911

G

H

estrogen receptor binding site associated antigen 9

disease_progression

protein:increased expression:uterine cervix

RGD

NCBI chr 8:109,539,702...109,565,996
Ensembl chr 8:109,539,711...109,570,072

G

N

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

NCBI chrNW_004624765:3,612,781...4,742,219
Ensembl chrNW_004624765:3,613,379...4,734,585

G

G

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

NCBI chr10:97,099,090...98,281,697

G

P

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

NCBI chr15:113,966,573...115,096,984
Ensembl chr15:113,974,437...115,096,565

G

S

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

NCBI chrNW_004936586:4,065,767...5,100,690
Ensembl chrNW_004936586:4,066,498...5,100,035

G

D

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

NCBI chr37:19,029,647...20,134,576
Ensembl chr37:19,037,217...20,134,426

G

B

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

NCBI chr2B:98,625,630...99,795,371
Ensembl chr2B:217,069,644...218,272,006

G

C

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

NCBI chrNW_004955457:3,177,905...4,236,152
Ensembl chrNW_004955457:3,177,991...4,228,558

G

R

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

RGD

NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595

G

M

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

RGD

NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218

G

H

erb-b2 receptor tyrosine kinase 4

protein:increased expression: uterine cervix, cytoplasm

RGD

NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841

G

N

FA complementation group A

no_association

DNA:SNP: :rs11649196 (human)
DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)

PMID:19012493 PMID:21543111

RGD:11344886 RGD:11344901

NCBI chrNW_004624746:206,069...253,473
Ensembl chrNW_004624746:215,193...252,569

G

G

FA complementation group A

no_association

DNA:SNP: :rs11649196 (human)
DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)

PMID:19012493 PMID:21543111

RGD:11344886 RGD:11344901

NCBI chr 5:75,073,161...75,149,110
Ensembl chr 5:75,073,358...75,148,591

G

P

FA complementation group A

no_association

DNA:SNP: :rs11649196 (human)
DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)

PMID:19012493 PMID:21543111

RGD:11344886 RGD:11344901

NCBI chr 6:253,207...300,159
Ensembl chr 6:253,207...300,152

G

S

FA complementation group A

no_association

DNA:SNP: :rs11649196 (human)
DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)

PMID:19012493 PMID:21543111

RGD:11344886 RGD:11344901

NCBI chrNW_004936641:281,119...319,796
Ensembl chrNW_004936641:281,073...324,053

G

D

FA complementation group A

no_association

DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)
DNA:SNP: :rs11649196 (human)

PMID:19012493 PMID:21543111

RGD:11344886 RGD:11344901

NCBI chr 5:63,778,149...63,838,869
Ensembl chr 5:63,778,212...63,838,823

G

B

FA complementation group A

no_association

DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)
DNA:SNP: :rs11649196 (human)

PMID:19012493 PMID:21543111

RGD:11344886 RGD:11344901

NCBI chr16:70,495,310...70,579,275
Ensembl chr16:90,163,950...90,245,147

G

C

FA complementation group A

no_association

DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)
DNA:SNP: :rs11649196 (human)

PMID:19012493 PMID:21543111

RGD:11344886 RGD:11344901

NCBI chrNW_004955541:3,272,936...3,320,229
Ensembl chrNW_004955541:3,273,022...3,320,052

G

R

FA complementation group A

no_association

DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)
DNA:SNP: :rs11649196 (human)

RGD

PMID:19012493 PMID:21543111

RGD:11344886, RGD:11344901

NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527

G

M

Fanconi anemia, complementation group A

no_association

DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)
DNA:SNP: :rs11649196 (human)

RGD

PMID:19012493 PMID:21543111

RGD:11344886, RGD:11344901

NCBI chr 8:123,993,033...124,045,390
Ensembl chr 8:123,995,039...124,045,315

G

H

FA complementation group A

no_association

DNA:SNPs, haplotypes: :[rs2239359, rs7190823, rs7195066 (human)
DNA:SNP: :rs11649196 (human)

RGD

PMID:19012493 PMID:21543111

RGD:11344886, RGD:11344901

NCBI chr16:89,737,549...89,816,647
Ensembl chr16:89,726,683...89,816,977

G

N

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chrNW_004624755:25,633,690...25,647,361
Ensembl chrNW_004624755:25,635,165...25,646,932

G

G

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chr27:46,958,444...46,974,032
Ensembl chr27:46,957,254...46,973,392

G

P

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chr 8:879,151...894,968
Ensembl chr 8:879,159...894,964

G

S

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chrNW_004936477:21,591,772...21,606,289
Ensembl chrNW_004936477:21,591,792...21,606,296

G

D

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chr 3:62,309,128...62,318,932
Ensembl chr 3:62,303,756...62,323,896

G

B

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chr 4:1,933,172...1,948,742
Ensembl chr 4:1,843,774...1,861,692

G

C

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chrNW_004955514:1,030,244...1,038,590
Ensembl chrNW_004955514:1,025,600...1,038,590

G

R

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341

G

M

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of cervix | ClinVar Annotator: match by term: Cervical cancer | ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

H

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cervical cancer
ClinVar Annotator: match by term: Cancer of cervix
ClinVar Annotator: match by term: Cervix cancer

PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More...

NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872

G

B

glutathione S-transferase mu 1

susceptibility

Ensembl chr 1:127,979,238...128,010,411

G

R

glutathione S-transferase mu 1

susceptibility

RGD

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

M

glutathione S-transferase, mu 1

susceptibility

RGD

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

H

glutathione S-transferase mu 1

susceptibility

RGD

NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039

G

R

glutathione S-transferase theta 1

susceptibility

RGD

NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585

G

M

glutathione S-transferase, theta 1

susceptibility

RGD

NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418

G

H

glutathione S-transferase theta 1

susceptibility

RGD

G

M

histocompatibility 2, class II antigen A, beta 1

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-DQB1 G > A (rs6457617)(human)
DNA:polymorphisms::HLA-DQB1*050201, DQB1*060101, DQB1*0602(human)

RGD

PMID:25893807 PMID:16425277

RGD:36174015, RGD:36174023

NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393

G

M

histocompatibility 2, M region locus 2

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-B7

RGD

NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443

G

H

major histocompatibility complex, class I, B

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-B7

RGD

NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067

G

H

major histocompatibility complex, class II, DP beta 1

susceptibility

DNA:polymorphism: :HLA-DPB1*1301 (human)

RGD

NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,990...33,089,696

G

H

major histocompatibility complex, class II, DQ beta 1

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-DQB1 G > A (rs6457617)(human)
DNA:polymorphisms::HLA-DQB1*050201, DQB1*060101, DQB1*0602(human)

RGD

PMID:25893807 PMID:16425277

RGD:36174015, RGD:36174023

NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383

G

N

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

NCBI chrNW_004624825:7,198,387...7,276,936
Ensembl chrNW_004624825:7,205,292...7,276,889

G

G

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

NCBI chr29:21,677,871...21,737,607
Ensembl chr29:21,678,559...21,731,430

G

P

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

NCBI chr 7:77,921,098...77,978,550
Ensembl chr 7:77,921,145...77,973,078

G

S

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

NCBI chrNW_004936880:368,041...425,967

G

B

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

NCBI chr14:2,022,280...2,083,215

G

C

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

NCBI chrNW_004955550:1,949,975...2,002,297
Ensembl chrNW_004955550:1,949,975...2,002,297

G

R

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

RGD

NCBI chr15:24,779,593...24,809,213
Ensembl chr15:24,779,450...24,809,183

G

M

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

RGD

NCBI chr14:52,310,834...52,341,462
Ensembl chr14:52,310,834...52,341,485

G

H

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

RGD

NCBI chr14:21,209,147...21,269,442
Ensembl chr14:21,209,136...21,269,494

G

N

homeobox B13

mRNA:increased expression:uterine cervix

NCBI chrNW_004624795:5,198,805...5,201,079
Ensembl chrNW_004624795:5,198,751...5,200,961

G

G

homeobox B13

mRNA:increased expression:uterine cervix

NCBI chr16:69,137,561...69,141,615
Ensembl chr16:69,137,585...69,139,382

G

P

homeobox B13

mRNA:increased expression:uterine cervix

NCBI chr12:24,948,307...24,950,661
Ensembl chr12:24,947,687...24,950,714

G

S

homeobox B13

mRNA:increased expression:uterine cervix

NCBI chrNW_004936490:12,688,572...12,690,908
Ensembl chrNW_004936490:12,688,559...12,690,908

G

D

homeobox B13

mRNA:increased expression:uterine cervix

NCBI chr 9:24,958,020...24,961,353
Ensembl chr 9:24,959,183...24,961,588

G

B

homeobox B13

mRNA:increased expression:uterine cervix

NCBI chr17:8,807,988...8,810,362
Ensembl chr17:8,994,224...8,996,598

G

C

homeobox B13

mRNA:increased expression:uterine cervix

NCBI chrNW_004955451:12,536,415...12,538,169
Ensembl chrNW_004955451:12,536,415...12,538,169

G

R

homeo box B13

mRNA:increased expression:uterine cervix

RGD

NCBI chr10:81,160,498...81,162,777
Ensembl chr10:81,160,498...81,162,777

G

M

homeobox B13

mRNA:increased expression:uterine cervix

RGD

NCBI chr11:96,085,142...96,087,436
Ensembl chr11:96,085,142...96,088,273

G

H

homeobox B13

mRNA:increased expression:uterine cervix

RGD

NCBI chr17:48,724,763...48,728,750
Ensembl chr17:48,724,763...48,728,750

G

N

heat shock protein family A (Hsp70) member 8

Protein: increased expression

NCBI chrNW_004624880:2,070,410...2,075,069
Ensembl chrNW_004624880:2,070,523...2,079,421

G

G

heat shock protein family A (Hsp70) member 8

Protein: increased expression

NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562

G

P

heat shock protein family A (Hsp70) member 8

Protein: increased expression

NCBI chr 9:49,982,278...49,986,760
Ensembl chr 9:49,982,284...49,990,508

G

S

heat shock protein family A (Hsp70) member 8

Protein: increased expression

NCBI chrNW_004936542:7,577,192...7,581,598
Ensembl chrNW_004936542:7,577,149...7,581,923

G

D

heat shock protein family A (Hsp70) member 8

Protein: increased expression

NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797

G

B

heat shock protein family A (Hsp70) member 8

Protein: increased expression

NCBI chr11:117,890,545...117,895,262
Ensembl chr11:121,809,800...121,815,773

G

C

heat shock protein family A (Hsp70) member 8

Protein: increased expression

NCBI chrNW_004955412:23,863,513...23,867,984
Ensembl chrNW_004955412:23,862,590...23,867,984

G

R

heat shock protein family A (Hsp70) member 8

Protein: increased expression

RGD

NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259

G

M

heat shock protein 8

Protein: increased expression

RGD

NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383

G

H

heat shock protein family A (Hsp70) member 8

Protein: increased expression

RGD

NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230

G

N

interleukin 10

disease_progression

protein:increased expression:serum

NCBI chrNW_004624807:4,687,249...4,691,658
Ensembl chrNW_004624807:4,687,176...4,691,732

G

G

interleukin 10

disease_progression

protein:increased expression:serum

NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836

G

P

interleukin 10

disease_progression

protein:increased expression:serum

NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378

G

S

interleukin 10

disease_progression

protein:increased expression:serum

NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502

G

D

interleukin 10

disease_progression

protein:increased expression:serum

NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057

G

B

interleukin 10

disease_progression

protein:increased expression:serum

NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371

G

C

interleukin 10

disease_progression

protein:increased expression:serum

NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779

G

R

interleukin 10

disease_progression

protein:increased expression:serum

RGD

NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313

G

M

interleukin 10

disease_progression

protein:increased expression:serum

RGD

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

H

interleukin 10

disease_progression

protein:increased expression:serum

RGD

NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541

G

N

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760

G

G

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729

G

S

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165

G

D

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458

G

B

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424

G

C

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947

G

R

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

RGD

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

M

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

RGD

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

H

interleukin 1 beta

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

RGD

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

N

lysine demethylase 3A

severity

human gene in a mouse model

NCBI chrNW_004624749:16,784,538...16,829,784
Ensembl chrNW_004624749:16,784,538...16,829,365

G

G

lysine demethylase 3A

severity

human gene in a mouse model

NCBI chr14:20,668,215...20,721,854
Ensembl chr14:20,668,821...20,720,759

G

P

lysine demethylase 3A

severity

human gene in a mouse model

NCBI chr 3:58,300,109...58,355,000
Ensembl chr 3:58,302,949...58,354,945

G

S

lysine demethylase 3A

severity

human gene in a mouse model

NCBI chrNW_004936712:1,053,210...1,097,845
Ensembl chrNW_004936712:1,053,210...1,096,961

G

D

lysine demethylase 3A

severity

human gene in a mouse model

NCBI chr17:38,690,962...38,744,507
Ensembl chr17:38,690,979...38,743,739

G

B

lysine demethylase 3A

severity

human gene in a mouse model

NCBI chr2A:86,497,531...86,548,772

G

C

lysine demethylase 3A

severity

human gene in a mouse model

NCBI chrNW_004955424:1,164,384...1,218,607
Ensembl chrNW_004955424:1,171,827...1,218,607

G

R

lysine demethylase 3A

severity

human gene in a mouse model

RGD

NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073

G

M

lysine (K)-specific demethylase 3A

severity

human gene in a mouse model

RGD

NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974

G

H

lysine demethylase 3A

severity

human gene in a mouse model

RGD

NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716

G

N

lysine methyltransferase 2A

human gene in a mouse model

NCBI chrNW_004624784:13,824,507...13,912,672
Ensembl chrNW_004624784:13,824,541...13,908,077

G

G

lysine methyltransferase 2A

human gene in a mouse model

NCBI chr 1:109,819,748...109,912,763
Ensembl chr 1:109,853,758...109,908,113

G

P

lysine methyltransferase 2A

human gene in a mouse model

NCBI chr 9:45,743,566...45,828,559
Ensembl chr 9:45,743,397...45,824,884

G

S

lysine methyltransferase 2A

human gene in a mouse model

NCBI chrNW_004936542:3,480,071...3,566,823
Ensembl chrNW_004936542:3,391,774...3,562,147

G

D

lysine methyltransferase 2A

human gene in a mouse model

NCBI chr 5:15,212,559...15,302,825
Ensembl chr 5:15,217,348...15,270,971

G

B

lysine methyltransferase 2A

human gene in a mouse model

NCBI chr11:113,273,198...113,364,404
Ensembl chr11:117,204,820...117,290,100

G

C

lysine methyltransferase 2A

human gene in a mouse model

NCBI chrNW_004955412:19,586,435...19,670,149
Ensembl chrNW_004955412:19,586,141...19,665,527

G

R

lysine methyltransferase 2A

human gene in a mouse model

RGD

NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181

G

M

lysine (K)-specific methyltransferase 2A

human gene in a mouse model

RGD

NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594

G

H

lysine methyltransferase 2A

human gene in a mouse model

RGD

NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832

G

N

lysine methyltransferase 2E (inactive)

human gene in a mouse model

NCBI chrNW_004624739:24,371,415...24,476,245
Ensembl chrNW_004624739:24,372,237...24,476,137

G

G

lysine methyltransferase 2E (inactive)

human gene in a mouse model

NCBI chr21:73,930,957...74,030,434
Ensembl chr21:73,930,932...74,029,673

G

P

lysine methyltransferase 2E (inactive)

human gene in a mouse model

NCBI chr 9:104,876,301...105,007,161
Ensembl chr 9:104,911,821...105,007,084

G

S

lysine methyltransferase 2E (inactive)

human gene in a mouse model

NCBI chrNW_004936479:18,674,657...18,764,177
Ensembl chrNW_004936479:18,675,413...18,738,983

G

D

lysine methyltransferase 2E (inactive)

human gene in a mouse model

NCBI chr18:15,240,631...15,332,850
Ensembl chr18:15,239,994...15,332,828

G

B

lysine methyltransferase 2E (inactive)

human gene in a mouse model

NCBI chr 7:97,001,250...97,099,956
Ensembl chr 7:109,734,808...109,832,851

G

C

lysine methyltransferase 2E (inactive)

human gene in a mouse model

NCBI chrNW_004955410:9,714,587...9,808,021

G

R

lysine methyltransferase 2E

human gene in a mouse model

RGD

NCBI chr 4:11,658,218...11,727,373
Ensembl chr 4:11,658,979...11,727,373

G

M

lysine (K)-specific methyltransferase 2E

human gene in a mouse model

RGD

NCBI chr 5:23,638,034...23,709,233
Ensembl chr 5:23,639,439...23,709,233

G

H

lysine methyltransferase 2E (inactive)

human gene in a mouse model

RGD

NCBI chr 7:105,014,205...105,115,019
Ensembl chr 7:104,940,943...105,115,019

G

H

long intergenic non-protein coding RNA 885

mRNA:increased expression:cervical region (human)
human cells in mouse model

RGD

PMID:33603486 PMID:33603486

RGD:152999025, RGD:152999025

NCBI chr 3:196,142,636...196,160,890
Ensembl chr 3:196,142,516...196,160,893

G

P

baculoviral IAP repeat-containing protein 2

mRNA:decreased expression:uterine cervix

NCBI chr 9:33,041,592...33,062,865
Ensembl chr 9:33,041,663...33,062,854

G

P

tumor necrosis factor receptor superfamily member 10B-like

NCBI chr14:7,344,788...7,371,086

G

B

HLA class II histocompatibility antigen, DQ beta 1 chain

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-DQB1 G > A (rs6457617)(human)
DNA:polymorphisms::HLA-DQB1*050201, DQB1*060101, DQB1*0602(human)

PMID:16425277 PMID:25893807

RGD:36174015 RGD:36174023

NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272

G

B

class I histocompatibility antigen, Gogo-B*0101 alpha chain

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-B7

NCBI chr 6:31,106,562...31,109,933
Ensembl chr 6:31,997,381...32,000,067

G

B

HLA class II histocompatibility antigen, DP beta 1 chain

susceptibility

DNA:polymorphism: :HLA-DPB1*1301 (human)

NCBI chr 6:32,648,780...32,659,613
Ensembl chr 6:33,763,566...33,774,387

G

N

HLA class II histocompatibility antigen, DP beta 1 chain

susceptibility

DNA:polymorphism: :HLA-DPB1*1301 (human)

NCBI chrNW_004624754:23,661,031...23,672,549
Ensembl chrNW_004624754:23,658,339...23,672,663

G

N

HLA class II histocompatibility antigen, DQ beta 1 chain

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-DQB1 G > A (rs6457617)(human)
DNA:polymorphisms::HLA-DQB1*050201, DQB1*060101, DQB1*0602(human)

PMID:16425277 PMID:25893807

RGD:36174015 RGD:36174023

NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713

G

S

HLA class II histocompatibility antigen, DP beta 1 chain

susceptibility

DNA:polymorphism: :HLA-DPB1*1301 (human)

NCBI chrNW_004936476:25,730,800...25,741,089
Ensembl chrNW_004936476:25,730,596...25,741,145

G

C

HLA class II histocompatibility antigen, DP beta 1 chain

susceptibility

DNA:polymorphism: :HLA-DPB1*1301 (human)

NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042

G

G

glutathione S-transferase Mu 1

susceptibility

NCBI chr20:23,854,969...23,861,634

G

P

interleukin-1 beta-like

susceptibility

associated with Papillomavirus Infections;DNA:SNP:promoter: -511 C>T (rs16944)(human)

G

D

heterogeneous nuclear ribonucleoprotein C

protein:increased expression:cervical epithelium (human)

NCBI chr15:18,239,810...18,299,065

G

N

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

NCBI chrNW_004624739:10,387,745...10,467,384
Ensembl chrNW_004624739:10,435,761...10,467,543

G

G

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

NCBI chr21:38,015,409...38,091,907

G

P

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

NCBI chr 9:89,130,971...89,342,181
Ensembl chr 9:89,102,621...89,210,281

G

S

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

NCBI chrNW_004936546:6,169,789...6,188,403
Ensembl chrNW_004936546:6,167,616...6,232,771

G

D

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

NCBI chr14:34,189,983...34,271,998
Ensembl chr14:34,075,463...34,251,330

G

B

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

NCBI chr 7:20,826,105...20,904,602
Ensembl chr 7:20,144,960...20,170,423

G

C

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

NCBI chrNW_004955410:22,777,518...22,894,561
Ensembl chrNW_004955410:22,811,786...22,894,572

G

R

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

RGD

NCBI chr 6:140,352,690...140,430,255
Ensembl chr 6:140,352,755...140,430,255

G

M

metastasis associated in colon cancer 1

mRNA:increased expression:cervical region (human)

RGD

NCBI chr12:119,354,133...119,430,669
Ensembl chr12:119,278,005...119,433,722

G

H

MET transcriptional regulator MACC1

mRNA:increased expression:cervical region (human)

RGD

NCBI chr 7:20,134,655...20,217,384
Ensembl chr 7:20,134,655...20,217,404

G

N

mitogen-activated protein kinase kinase 3

treatment

NCBI chrNW_004624849:5,007,185...5,034,488
Ensembl chrNW_004624849:5,006,513...5,035,747

G

G

mitogen-activated protein kinase kinase 3

treatment

NCBI chr16:19,396,377...19,427,617
Ensembl chr16:19,396,452...19,427,652

G

P

mitogen-activated protein kinase kinase 3

treatment

NCBI chr12:61,396,337...61,417,333
Ensembl chr12:61,396,369...61,417,321

G

S

mitogen-activated protein kinase kinase 3

treatment

NCBI chrNW_004936741:362,682...386,633
Ensembl chrNW_004936741:362,387...386,678

G

D

mitogen-activated protein kinase kinase 3

treatment

NCBI chr 5:42,732,751...42,762,420
Ensembl chr 5:42,700,836...42,761,736

G

C

mitogen-activated protein kinase kinase 3

treatment

NCBI chrNW_004955577:1,225,033...1,249,510
Ensembl chrNW_004955577:1,237,287...1,248,541

G

R

mitogen activated protein kinase kinase 3

treatment

RGD

NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492

G

M

mitogen-activated protein kinase kinase 3

treatment

RGD

NCBI chr11:60,822,880...60,843,637
Ensembl chr11:60,822,859...60,843,637

G

H

mitogen-activated protein kinase kinase 3

treatment

RGD

NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,232

G

N

mitogen-activated protein kinase kinase 6

NCBI chrNW_004624870:4,224,108...4,420,217
Ensembl chrNW_004624870:4,287,835...4,416,559

G

G

mitogen-activated protein kinase kinase 6

NCBI chr16:52,045,398...52,188,416
Ensembl chr16:52,057,784...52,187,997

G

P

mitogen-activated protein kinase kinase 6

NCBI chr12:10,891,445...11,018,617
Ensembl chr12:10,894,966...11,018,641

G

D

mitogen-activated protein kinase kinase 6

NCBI chr 9:15,840,714...15,962,400
Ensembl chr 9:15,840,983...15,952,026

G

B

mitogen-activated protein kinase kinase 6

NCBI chr17:63,342,720...63,483,926
Ensembl chr17:68,730,011...68,870,454

G

C

mitogen-activated protein kinase kinase 6

NCBI chrNW_004955478:3,331,607...3,448,840
Ensembl chrNW_004955478:3,331,607...3,448,842

G

R

mitogen-activated protein kinase kinase 6

RGD

NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293

G

M

mitogen-activated protein kinase kinase 6

RGD

NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348

G

H

mitogen-activated protein kinase kinase 6

RGD

NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865

G

N

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

NCBI chrNW_004624754:25,007,866...25,020,950

G

G

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

NCBI chr17:41,735,584...41,754,618
Ensembl chr17:41,739,419...41,755,141

G

P

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

NCBI chr 7:23,229,508...23,247,739
Ensembl chr 7:23,229,510...23,245,575

G

S

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

NCBI chrNW_004936837:363,870...379,406
Ensembl chrNW_004936837:362,928...378,759

G

D

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

NCBI chr12:496,353...509,812
Ensembl chr12:496,878...507,442

G

B

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

NCBI chr 6:30,444,570...30,462,432
Ensembl chr 6:31,314,560...31,329,243

G

C

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

NCBI chrNW_004955583:688,288...722,393

G

R

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

RGD

NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240

G

M

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

RGD

NCBI chr17:36,152,390...36,170,562
Ensembl chr17:36,152,407...36,170,562

G

H

mediator of DNA damage checkpoint 1

mRNA, protein:increased expression:uterine cervix (human)

RGD

NCBI chr 6:30,699,807...30,717,281
Ensembl chr 6:30,699,807...30,717,447

G

N

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

NCBI chrNW_004624748:6,770,231...6,790,385

G

G

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

NCBI chr 3:25,990,203...26,009,472
Ensembl chr 3:25,990,159...26,009,438

G

P

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

NCBI chr11:19,551,858...19,566,915
Ensembl chr11:19,551,863...19,566,926

G

S

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

NCBI chrNW_004936565:1,397,434...1,414,674
Ensembl chrNW_004936565:1,396,088...1,415,248

G

D

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

NCBI chr22:3,396,276...3,411,037
Ensembl chr22:3,396,267...3,410,608

G

B

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

NCBI chr13:29,227,620...29,247,082
Ensembl chr13:47,929,918...47,948,836

G

C

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

NCBI chrNW_004955431:1,794,863...1,812,641
Ensembl chrNW_004955431:1,794,115...1,812,889

G

R

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

RGD

NCBI chr15:48,696,542...48,706,818
Ensembl chr15:48,696,511...48,706,820

G

M

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

RGD

NCBI chr14:73,747,489...73,755,985
Ensembl chr14:73,747,465...73,756,289

G

H

mediator complex subunit 4

severity

mRNA:decreased expression:uterine cervix (human)

RGD

NCBI chr13:48,075,724...48,095,104
Ensembl chr13:48,053,323...48,095,131

G

G

major histocompatibility complex, class II, DP beta 1

susceptibility

DNA:polymorphism: :HLA-DPB1*1301 (human)

NCBI chr17:38,996,329...39,007,097

G

P

microRNA mir-152

miRNA:decreased expression:uterine cervix

NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336

G

D

microRNA mir-152

miRNA:decreased expression:uterine cervix

NCBI chr 9:24,335,161...24,335,219
Ensembl chr 9:24,335,146...24,335,225

G

R

microRNA 152

miRNA:decreased expression:uterine cervix

RGD

NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020

G

M

microRNA 152

miRNA:decreased expression:uterine cervix

RGD

NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291

G

H

microRNA 152

miRNA:decreased expression:uterine cervix

RGD

NCBI chr17:48,037,161...48,037,247
Ensembl chr17:48,037,161...48,037,247

G

P

microRNA mir-21

severity

NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358

G

D

microRNA mir-21

severity

NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624

G

R

microRNA 21

severity

RGD

NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348

G

H

microRNA 21

severity

RGD

NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337

G

M

microRNA 21a

severity

RGD

NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984

G

P

microRNA mir-432

mRNA:decreased expression:cervical region (human)

NCBI chr 7:121,711,137...121,711,216
Ensembl chr 7:121,711,137...121,711,216

G

D

microRNA mir-432

mRNA:decreased expression:cervical region (human)

NCBI chr 8:69,106,415...69,106,501
Ensembl chr 8:69,106,415...69,106,501

G

M

microRNA 432

mRNA:decreased expression:cervical region (human)

RGD

NCBI chr12:109,561,390...109,561,464
Ensembl chr12:109,561,390...109,561,464

G

H

microRNA 432

mRNA:decreased expression:cervical region (human)

RGD

NCBI chr14:100,884,483...100,884,576
Ensembl chr14:100,884,483...100,884,576

G

N

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

NCBI chrNW_004624878:71,642...79,660
Ensembl chrNW_004624878:71,642...79,602

G

G

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

NCBI chr 1:94,167,507...94,177,357
Ensembl chr 1:94,167,219...94,176,767

G

P

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076

G

S

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

NCBI chrNW_004936551:5,167,909...5,175,149
Ensembl chrNW_004936551:5,168,044...5,174,857

G

D

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648

G

B

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

NCBI chr11:97,730,545...97,739,190
Ensembl chr11:101,221,393...101,230,104

G

R

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

RGD

NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097

G

H

matrix metallopeptidase 1

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

RGD

NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160

G

N

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

NCBI chrNW_004624918:2,228,688...2,239,852

G

G

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

NCBI chr 1:94,322,473...94,370,665
Ensembl chr 1:94,322,979...94,334,747

G

P

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162

G

S

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

NCBI chrNW_004936551:5,040,084...5,050,384
Ensembl chrNW_004936551:5,040,084...5,050,384

G

D

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121

G

B

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

NCBI chr11:97,890,811...97,902,778
Ensembl chr11:101,377,001...101,387,679

G

C

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

NCBI chrNW_004955412:6,106,994...6,118,760
Ensembl chrNW_004955412:6,106,994...6,118,760

G

R

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

RGD

NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239

G

M

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

RGD

NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331

G

H

matrix metallopeptidase 13

mRNA:increased expression:uterine cervix

RGD

NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732

G

M

matrix metallopeptidase 1a (interstitial collagenase)

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

RGD

NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857

G

M

matrix metallopeptidase 1b (interstitial collagenase)

disease_progression

DNA:insertion:promoter:g.-1607insG (human)

NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047

G

N

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chrNW_004624818:1,184,736...1,202,708
Ensembl chrNW_004624818:1,187,869...1,199,168

G

G

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950

G

P

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820

G

S

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193

G

D

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818

G

B

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chr 1:10,548,196...10,568,174
Ensembl chr 1:11,766,334...11,785,419

G

C

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240

G

R

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797

G

M

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008

G

H

methylenetetrahydrofolate reductase

susceptibility

DNA:missense mutation:cds:g.1298A>C (human)

RGD

NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455

G

N

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chrNW_004624751:873,575...880,266
Ensembl chrNW_004624751:873,599...880,266

G

G

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chr 4:1,643,810...1,658,651
Ensembl chr 4:1,643,822...1,658,858

G

P

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chr16:78,993,909...79,000,001
Ensembl chr16:78,993,913...79,000,006

G

S

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chrNW_004936815:144,994...157,788
Ensembl chrNW_004936815:144,994...158,144

G

D

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chr34:10,989,857...10,999,232
Ensembl chr34:10,989,828...11,001,053

G

B

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chr 5:2,132,177...2,147,226
Ensembl chr 5:1,854,644...1,869,711

G

C

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chrNW_004955504:893,112...903,282
Ensembl chrNW_004955504:893,112...903,282

G

R

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

NCBI chr 1:29,968,833...29,977,423
Ensembl chr 1:29,968,842...29,977,467

G

M

NADH:ubiquinone oxidoreductase core subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

RGD

NCBI chr13:73,467,995...73,476,574
Ensembl chr13:73,467,957...73,476,661

G

H

NADH:ubiquinone oxidoreductase subunit S6

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

RGD

NCBI chr 5:1,801,407...1,816,048
Ensembl chr 5:1,801,407...1,816,048

G

R

NADH:ubiquinone oxidoreductase subunit S6, pseudogene 1

disease_progression

DNA, mRNA:amplification, increased expression:uterine cervix

RGD

NCBI chr 2:27,201,706...27,202,241
Ensembl chr 2:27,201,713...27,202,258

G

N

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

NCBI chrNW_004624772:10,358,554...10,369,371

G

G

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

NCBI chr20:18,953,273...18,966,002
Ensembl chr20:18,953,883...18,961,931

G

P

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227

G

S

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590

G

D

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788

G

B

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

NCBI chr 1:87,837,146...87,850,013
Ensembl chr 1:122,890,505...122,903,585

G

C

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103

G

R

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

RGD

NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626

G

M

neuroblastoma ras oncogene

mRNA:increased expression:uterine cervix

RGD

NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230

G

H

NRAS proto-oncogene, GTPase

mRNA:increased expression:uterine cervix

RGD

NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771

G

N

phosphoglucomutase 3

NCBI chrNW_004624799:11,395,465...11,423,878
Ensembl chrNW_004624799:11,395,615...11,423,876

G

G

phosphoglucomutase 3

NCBI chr13:7,841,724...7,871,013
Ensembl chr13:7,844,765...7,871,002

G

P

phosphoglucomutase 3

NCBI chr 1:83,003,622...83,029,392
Ensembl chr 1:83,003,604...83,029,897

G

S

phosphoglucomutase 3

NCBI chrNW_004936510:7,586,817...7,622,586
Ensembl chrNW_004936510:7,586,837...7,609,267

G

D

phosphoglucomutase 3

NCBI chr12:43,582,472...43,611,583
Ensembl chr12:43,584,940...43,611,777

G

B

phosphoglucomutase 3

NCBI chr 6:81,062,356...81,090,215
Ensembl chr 6:84,336,092...84,364,515

G

C

phosphoglucomutase 3

NCBI chrNW_004955411:10,904,022...10,925,613
Ensembl chrNW_004955411:10,904,022...10,924,216

G

R

phosphoglucomutase 3

RGD

NCBI chr 8:87,518,317...87,536,021
Ensembl chr 8:87,517,701...87,536,022

G

M

phosphoglucomutase 3

RGD

NCBI chr 9:86,423,997...86,453,927
Ensembl chr 9:86,436,430...86,453,895

G

H

phosphoglucomutase 3

RGD

NCBI chr 6:83,148,705...83,193,900
Ensembl chr 6:83,147,324...83,193,936

G

N

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

NCBI chrNW_004624855:430,148...1,992,121
Ensembl chrNW_004624855:430,260...1,989,747

G

G

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

NCBI chr13:88,856,056...90,329,379

G

P

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

NCBI chr 1:5,698,508...6,731,132
Ensembl chr 1:5,465,312...6,730,872

G

S

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

NCBI chrNW_004936489:12,118,538...12,913,664
Ensembl chrNW_004936489:12,120,678...13,327,872

G

D

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

NCBI chr 1:49,886,887...51,201,930
Ensembl chr 1:49,889,005...51,201,764

G

B

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

NCBI chr 6:159,293,016...160,679,106
Ensembl chr 6:164,314,990...165,678,770

G

C

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

NCBI chrNW_004955439:18,664,230...19,953,358
Ensembl chrNW_004955439:18,664,379...19,951,152

G

R

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

RGD

NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555

G

M

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

RGD

NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248

G

H

parkin RBR E3 ubiquitin protein ligase

disease_progression

protein:decreased expression:uterine cervix (human)

RGD

NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775

G

N

protein tyrosine kinase 2

disease_progression

NCBI chrNW_004624735:15,356,911...15,713,219
Ensembl chrNW_004624735:15,461,178...15,714,071

G

G

protein tyrosine kinase 2

disease_progression

NCBI chr 8:134,897,511...135,246,300

G

P

protein tyrosine kinase 2

disease_progression

NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054

G

S

protein tyrosine kinase 2

disease_progression

NCBI chrNW_004936470:10,379,855...10,578,531
Ensembl chrNW_004936470:10,379,872...10,578,543

G

D

protein tyrosine kinase 2

disease_progression

NCBI chr13:35,302,439...35,541,336
Ensembl chr13:35,303,380...35,541,294

G

B

protein tyrosine kinase 2

disease_progression

NCBI chr 8:137,330,777...137,677,306
Ensembl chr 8:140,412,773...140,684,898

G

C

protein tyrosine kinase 2

disease_progression

NCBI chrNW_004955461:14,337,914...14,622,779
Ensembl chrNW_004955461:14,337,914...14,556,931

G

R

protein tyrosine kinase 2

disease_progression

RGD

NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783

G

M

PTK2 protein tyrosine kinase 2

disease_progression

RGD

NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129

G

H

protein tyrosine kinase 2

disease_progression

RGD

NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216

G

N

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

NCBI chrNW_004624747:19,721,581...19,813,639
Ensembl chrNW_004624747:19,721,468...19,813,670

G

G

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

NCBI chr11:107,658,495...107,754,457
Ensembl chr11:107,658,453...107,752,637

G

P

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

NCBI chr14:39,202,165...39,292,041
Ensembl chr14:39,202,169...39,292,003

G

S

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

NCBI chrNW_004936668:2,602,261...2,687,903
Ensembl chrNW_004936668:2,628,706...2,682,448

G

D

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

NCBI chr26:9,989,218...10,072,245
Ensembl chr26:9,989,425...10,067,481

G

B

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

NCBI chr12:110,016,364...110,107,462
Ensembl chr12:113,435,669...113,503,762

G

C

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

NCBI chrNW_004955482:8,934,734...9,031,230
Ensembl chrNW_004955482:8,934,306...9,035,203

G

R

protein tyrosine phosphatase, non-receptor type 11

protein:increased expression:foreskin

RGD

NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925

G

M

protein tyrosine phosphatase, non-receptor type 11

protein:increased expression:foreskin

RGD

NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460

G

H

protein tyrosine phosphatase non-receptor type 11

protein:increased expression:foreskin

RGD

NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918

G

N

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

NCBI chrNW_004624860:3,580,225...3,595,403
Ensembl chrNW_004624860:3,580,560...3,595,090

G

G

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

NCBI chr11:6,977,480...6,994,525
Ensembl chr11:6,984,710...6,994,545

G

P

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

NCBI chr 5:63,762,109...63,779,086
Ensembl chr 5:63,762,112...63,808,350

G

S

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

NCBI chrNW_004936709:864,206...884,630
Ensembl chrNW_004936709:864,197...884,610

G

D

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

NCBI chr27:38,084,976...38,101,552
Ensembl chr27:38,084,980...38,101,937

G

B

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

NCBI chr12:7,075,879...7,093,041
Ensembl chr12:6,991,099...7,008,830

G

C

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

NCBI chrNW_004955413:4,525,954...4,547,177
Ensembl chrNW_004955413:4,525,954...4,547,177

G

R

protein tyrosine phosphatase, non-receptor type 6

protein:increased expression:foreskin

RGD

NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984

G

M

protein tyrosine phosphatase, non-receptor type 6

protein:increased expression:foreskin

RGD

NCBI chr 6:124,697,670...124,715,672
Ensembl chr 6:124,697,670...124,715,677

G

H

protein tyrosine phosphatase non-receptor type 6

protein:increased expression:foreskin

RGD

NCBI chr12:6,946,577...6,961,316
Ensembl chr12:6,946,468...6,961,316

G

N

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

NCBI chrNW_004624730:4,181,207...4,190,603
Ensembl chrNW_004624730:4,181,462...4,190,431

G

G

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

NCBI chr22:11,716,969...11,728,646
Ensembl chr22:11,716,918...11,725,027

G

P

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

NCBI chr13:32,816,156...32,825,486
Ensembl chr13:32,816,156...32,825,226

G

S

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

NCBI chrNW_004936529:1,857,177...1,866,198
Ensembl chrNW_004936529:1,857,145...1,867,260

G

D

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

NCBI chr20:39,014,639...39,023,393
Ensembl chr20:39,014,666...39,022,585

G

B

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

NCBI chr 3:50,255,897...50,267,042
Ensembl chr 3:51,491,548...51,502,392

G

C

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

NCBI chrNW_004955532:2,132,892...2,142,106
Ensembl chrNW_004955532:2,132,822...2,142,106

G

R

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

RGD

NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164

G

M

Ras association (RalGDS/AF-6) domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

RGD

NCBI chr 9:107,428,752...107,439,460
Ensembl chr 9:107,428,754...107,439,466

G

H

Ras association domain family member 1

associated with Papillomavirus Infections;DNA:hypermethylation:promoter

RGD

NCBI chr 3:50,329,788...50,340,836
Ensembl chr 3:50,329,782...50,340,980

G

R

RT1 class II, locus Bb

susceptibility

associated with Papillomavirus Infections;DNA:polymorphism: :HLA-DQB1 G > A (rs6457617)(human)
DNA:polymorphisms::HLA-DQB1*050201, DQB1*060101, DQB1*0602(human)

RGD

PMID:25893807 PMID:16425277

RGD:36174015, RGD:36174023

NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597

G

R

RT1 class II, locus Hb, pseudogene 1

susceptibility

DNA:polymorphism: :HLA-DPB1*1301 (human)

NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618

G

N

splicing factor 3b subunit 4

severity

mRNA, protein:increased expression:cervix (human)
human cells in mouse model

NCBI chrNW_004624772:17,701,930...17,706,613
Ensembl chrNW_004624772:17,701,341...17,706,550

G

G

splicing factor 3b subunit 4

severity

mRNA, protein:increased expression:cervix (human)
human cells in mouse model

G

P

splicing factor 3b subunit 4

severity

human cells in mouse model
mRNA, protein:increased expression:cervix (human)

NCBI chr 4:99,123,564...99,129,218
Ensembl chr 4:99,123,585...99,129,218

G

S

splicing factor 3b subunit 4

severity

human cells in mouse model
mRNA, protein:increased expression:cervix (human)

NCBI chrNW_004936580:260,013...265,057

G

D

splicing factor 3b subunit 4

severity

human cells in mouse model
mRNA, protein:increased expression:cervix (human)

NCBI chr17:59,208,989...59,214,643
Ensembl chr17:59,208,990...59,213,991

G

B

splicing factor 3b subunit 4

severity

mRNA, protein:increased expression:cervix (human)
human cells in mouse model

NCBI chr 1:125,268,113...125,273,405
Ensembl chr 1:128,924,317...128,929,610

G

C

splicing factor 3b subunit 4

severity

human cells in mouse model
mRNA, protein:increased expression:cervix (human)

NCBI chrNW_004955413:826,190...830,502
Ensembl chrNW_004955413:826,190...832,496

G

R

splicing factor 3B subunit 4

severity

mRNA, protein:increased expression:cervix (human)
human cells in mouse model

RGD

PMID:35853859 PMID:35853859

RGD:155882439, RGD:155882439

NCBI chr 2:183,732,791...183,737,545
Ensembl chr 2:183,732,754...183,737,959

G

M

splicing factor 3b, subunit 4

severity

mRNA, protein:increased expression:cervix (human)
human cells in mouse model

RGD

PMID:35853859 PMID:35853859

RGD:155882439, RGD:155882439

NCBI chr 3:96,079,822...96,084,880
Ensembl chr 3:96,079,648...96,084,880

G

H

splicing factor 3b subunit 4

severity

mRNA, protein:increased expression:cervix (human)
human cells in mouse model

RGD

PMID:35853859 PMID:35853859

RGD:155882439, RGD:155882439

NCBI chr 1:149,923,317...149,927,803
Ensembl chr 1:149,923,317...149,927,803

G

N

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

NCBI chrNW_004624778:11,380,656...11,460,566
Ensembl chrNW_004624778:11,384,769...11,501,078

G

G

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

NCBI chr18:33,017,138...33,105,320
Ensembl chr18:33,017,492...33,104,606

G

P

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

NCBI chr 1:97,415,360...97,511,388
Ensembl chr 1:97,415,716...97,511,357

G

S

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

NCBI chrNW_004936497:14,723,199...14,812,160
Ensembl chrNW_004936497:14,723,199...14,801,697

G

D

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

NCBI chr 7:43,696,883...43,778,063
Ensembl chr 7:43,700,445...43,769,983

G

B

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

NCBI chr18:41,213,001...41,309,902
Ensembl chr18:44,580,905...44,668,530

G

C

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

NCBI chrNW_004955402:33,131,760...33,217,144
Ensembl chrNW_004955402:33,136,778...33,216,844

G

R

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

RGD

NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323

G

M

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

RGD

NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034

G

H

SMAD family member 2

DNA, mRNA:insertion, deletion, decreased expression:uterine cervix

RGD

NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146

G

N

SMAD family member 4

mRNA:decreased expression:uterine cervix

NCBI chrNW_004624778:14,570,025...14,629,950
Ensembl chrNW_004624778:14,570,348...14,630,325

G

G

SMAD family member 4

mRNA:decreased expression:uterine cervix

NCBI chr18:29,894,157...29,951,445
Ensembl chr18:29,897,621...29,934,478

G

P

SMAD family member 4

mRNA:decreased expression:uterine cervix

NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029

G

S

SMAD family member 4

mRNA:decreased expression:uterine cervix

NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123

G

D

SMAD family member 4

mRNA:decreased expression:uterine cervix

NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405

G

B

SMAD family member 4

mRNA:decreased expression:uterine cervix

NCBI chr18:44,402,112...44,456,779
Ensembl chr18:47,764,568...47,797,359

G

C

SMAD family member 4

mRNA:decreased expression:uterine cervix

NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538

G

R

SMAD family member 4

mRNA:decreased expression:uterine cervix

RGD

NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438

G

M

SMAD family member 4

mRNA:decreased expression:uterine cervix

RGD

NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851

G

H

SMAD family member 4

mRNA:decreased expression:uterine cervix

RGD

NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045

G

N

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

NCBI chrNW_004624738:20,466,120...20,591,966
Ensembl chrNW_004624738:20,466,117...20,591,910

G

G

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

NCBI chr14:68,259,509...68,404,167
Ensembl chr14:68,259,360...68,399,895

G

P

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

NCBI chr 3:101,209,568...101,366,057
Ensembl chr 3:101,209,641...101,362,723

G

S

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

NCBI chrNW_004936508:12,162,553...12,281,812
Ensembl chrNW_004936508:12,162,547...12,281,820

G

D

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

NCBI chr17:31,007,940...31,181,569
Ensembl chr17:31,009,257...31,142,063

G

B

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

NCBI chr2A:39,019,046...39,162,248
Ensembl chr2A:39,773,760...39,911,961

G

C

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

NCBI chrNW_004955441:6,649,895...6,724,271
Ensembl chrNW_004955441:6,646,385...6,713,028

G

R

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

RGD

NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107

G

M

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

RGD

NCBI chr17:80,701,181...80,787,882
Ensembl chr17:80,701,180...80,787,882

G

H

SOS Ras/Rac guanine nucleotide exchange factor 1

mRNA:increased expression:cervix epithelium (human)

RGD

NCBI chr 2:38,981,549...39,124,868
Ensembl chr 2:38,962,206...39,124,345

G

N

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

NCBI chrNW_004624786:1,163,350...1,183,071
Ensembl chrNW_004624786:1,163,606...1,182,764

G

G

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

NCBI chr16:22,347,213...22,370,531
Ensembl chr16:22,346,701...22,369,915

G

P

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

NCBI chr12:44,827,947...44,848,527
Ensembl chr12:44,827,949...44,848,566

G

S

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

NCBI chrNW_004936538:4,803,536...4,821,034
Ensembl chrNW_004936538:4,803,585...4,820,885

G

D

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

NCBI chr 9:42,783,224...42,804,568
Ensembl chr 9:42,783,235...42,804,456

G

B

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

NCBI chr17:28,176,288...28,198,493
Ensembl chr17:28,680,492...28,702,050

G

C

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

NCBI chrNW_004955481:4,558,748...4,576,320
Ensembl chrNW_004955481:4,558,851...4,576,038

G

R

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

RGD

NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745

G

M

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

RGD

NCBI chr11:78,192,412...78,213,283
Ensembl chr11:78,192,355...78,213,283

G

H

sperm associated antigen 5

severity

mRNA, protein:increased expression:cervix (human)

RGD

NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025

G

N

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chrNW_004624754:23,815,464...23,822,480
Ensembl chrNW_004624754:23,815,915...23,822,827

G

G

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr17:39,252,000...39,260,195

G

P

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr 7:25,062,772...25,071,989
Ensembl chr 7:25,062,771...25,074,843

G

S

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chrNW_004936476:25,899,514...25,907,690
Ensembl chrNW_004936476:25,899,339...25,907,695

G

D

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr12:2,424,049...2,432,165
Ensembl chr12:2,378,126...2,432,303

G

B

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr 6:32,414,665...32,423,488
Ensembl chr 6:33,530,171...33,538,978

G

C

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chrNW_004955437:1,504,549...1,511,110
Ensembl chrNW_004955437:1,504,947...1,511,097

G

R

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

RGD

PMID:18248301 PMID:12648582

RGD:6482260, RGD:6482272

NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901

G

M

transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)

susceptibility

DNA:SNPs: :

RGD

PMID:18248301 PMID:12648582

RGD:6482260, RGD:6482272

NCBI chr17:34,406,530...34,416,199
Ensembl chr17:34,406,527...34,416,199

G

H

transporter 1, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

RGD

PMID:18248301 PMID:12648582

RGD:6482260, RGD:6482272

NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816

G

N

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chrNW_004624754:23,827,782...23,845,690
Ensembl chrNW_004624754:23,827,706...23,837,356

G

G

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr17:39,266,870...39,277,658

G

P

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr 7:25,045,085...25,056,915
Ensembl chr 7:25,045,685...25,056,300

G

S

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chrNW_004936476:25,913,699...25,923,419
Ensembl chrNW_004936476:25,913,663...25,923,427

G

D

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr12:2,407,512...2,417,469
Ensembl chr12:2,378,126...2,432,303

G

B

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chr 6:32,394,586...32,408,297
Ensembl chr 6:33,507,332...33,523,750

G

C

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

PMID:12648582 PMID:18248301

RGD:6482260 RGD:6482272

NCBI chrNW_004955437:1,480,217...1,499,032
Ensembl chrNW_004955437:1,477,341...1,498,575

G

R

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

RGD

PMID:18248301 PMID:12648582

RGD:6482260, RGD:6482272

NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407

G

M

transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)

susceptibility

DNA:SNPs: :

RGD

PMID:18248301 PMID:12648582

RGD:6482260, RGD:6482272

NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295

G

H

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNPs: :

RGD

PMID:18248301 PMID:12648582

RGD:6482260, RGD:6482272

NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739

G

N

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

NCBI chrNW_004624956:331,275...341,561
Ensembl chrNW_004624956:330,327...337,299

G

G

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr22:48,134,133...48,140,870
Ensembl chr22:48,134,637...48,140,600

G

P

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr13:68,179,803...68,191,199
Ensembl chr13:68,179,806...68,190,942

G

S

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

NCBI chrNW_004936602:1,488,993...1,496,108
Ensembl chrNW_004936602:1,489,545...1,495,478

G

D

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr20:6,399,522...6,405,089
Ensembl chr20:6,399,522...6,405,089

G

B

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr 3:12,079,195...12,087,485
Ensembl chr 3:12,425,429...12,433,192

G

C

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

NCBI chrNW_004955429:14,689,016...14,693,211
Ensembl chrNW_004955429:14,685,031...14,693,211

G

R

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

RGD

NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558

G

M

tissue inhibitor of metalloproteinase 4

disease_progression

mRNA:increased expression:uterine cervix

RGD

NCBI chr 6:115,221,405...115,229,166
Ensembl chr 6:115,218,853...115,229,166

G

H

TIMP metallopeptidase inhibitor 4

disease_progression

mRNA:increased expression:uterine cervix

RGD

NCBI chr 3:12,153,068...12,158,912
Ensembl chr 3:12,153,068...12,158,912

G

N

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531

G

G

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

G

P

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416

G

S

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766

G

D

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425

G

B

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381

G

C

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700

G

R

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

RGD

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

G

M

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

H

tumor necrosis factor

susceptibility

DNA:polymorphism:promoter:-308G>A (human)

RGD

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

G

TNF receptor superfamily member 10a

NCBI chr 8:21,318,987...21,351,641
Ensembl chr 8:21,315,149...21,351,673

G

B

TNF receptor superfamily member 10a

NCBI chr 8:22,440,502...22,476,790
Ensembl chr 8:19,378,547...19,414,724

G

H

TNF receptor superfamily member 10a

RGD

NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102

G

R

TNF receptor superfamily member 10b

RGD

NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467

G

M

tumor necrosis factor receptor superfamily, member 10b

RGD

NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860

G

N

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chrNW_004624786:10,266,316...10,282,664
Ensembl chrNW_004624786:10,263,518...10,271,218

G

G

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223

G

P

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818

G

S

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425

G

D

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109

G

B

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120

G

C

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928

G

R

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

H

tumor protein p53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

N

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

NCBI chrNW_004624818:6,775,588...6,817,187
Ensembl chrNW_004624818:6,775,599...6,809,289

G

G

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

NCBI chr20:127,958,002...128,035,792
Ensembl chr20:127,958,809...128,013,691

G

P

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

NCBI chr 6:65,169,770...65,228,997
Ensembl chr 6:65,182,456...65,228,990

G

S

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

NCBI chrNW_004936737:171,894...211,464
Ensembl chrNW_004936737:172,467...211,464

G

D

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

NCBI chr 5:58,194,385...58,241,159
Ensembl chr 5:58,187,826...58,240,839

G

B

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

NCBI chr 1:2,323,399...2,405,295
Ensembl chr 1:3,476,064...3,529,206

G

C

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

NCBI chrNW_004955486:7,914,608...7,961,992
Ensembl chrNW_004955486:7,914,440...7,952,982

G

R

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

RGD

NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128

G

H

tumor protein p73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

RGD

NCBI chr 1:3,652,516...3,736,201
Ensembl chr 1:3,652,516...3,736,201

G

M

transformation related protein 53

ClinVar Annotator: match by term: Cancer of cervix

PMID:1349102 PMID:1849234 PMID:9407971 PMID:12826609 PMID:15982667 More...

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

M

transformation related protein 73

susceptibility

DNA:SNPs:exon 2:4G>A, 14C>T (rs2273953, rs1801173) (human)

RGD

NCBI chr 4:154,140,706...154,224,332
Ensembl chr 4:154,140,706...154,224,665

G

N

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

NCBI chrNW_004624907:1,087,611...1,113,275
Ensembl chrNW_004624907:1,087,611...1,113,266

G

G

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

NCBI chr 6:37,062,149...37,095,138
Ensembl chr 6:37,060,439...37,095,094

G

P

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729

G

S

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

NCBI chrNW_004936706:752,571...783,746
Ensembl chrNW_004936706:751,108...783,777

G

D

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

NCBI chr 1:111,548,719...111,571,816
Ensembl chr 1:111,548,719...111,571,816

G

B

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

NCBI chr19:40,485,052...40,522,188
Ensembl chr19:49,094,014...49,125,520

G

C

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

NCBI chrNW_004955555:1,293,416...1,315,839
Ensembl chrNW_004955555:1,293,416...1,315,839

G

R

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

RGD

NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701

G

M

X-ray repair complementing defective repair in Chinese hamster cells 1

DNA:polymorphism: :p.R194W

RGD

NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865

G

H

X-ray repair cross complementing 1

DNA:polymorphism: :p.R194W

RGD

NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473

G

N

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

NCBI chrNW_004624746:15,094,890...15,330,653
Ensembl chrNW_004624746:15,098,960...15,254,127

G

G

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

NCBI chr 5:55,912,325...56,174,010
Ensembl chr 5:55,907,983...56,085,112

G

P

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

NCBI chr 6:15,693,987...15,941,301
Ensembl chr 6:15,698,199...15,863,270

G

S

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

NCBI chrNW_004936475:21,005,242...21,235,992
Ensembl chrNW_004936475:21,080,302...21,231,544

G

D

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

NCBI chr 5:78,450,963...78,635,615
Ensembl chr 5:78,455,005...78,610,033

G

B

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

NCBI chr16:51,936,471...52,209,695
Ensembl chr16:72,635,666...72,808,360

G

C

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

NCBI chrNW_004955484:5,470,203...5,746,325
Ensembl chrNW_004955484:5,474,769...5,789,707

G

R

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

RGD

NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771

G

M

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

RGD

NCBI chr 8:109,005,975...109,688,272
Ensembl chr 8:108,669,276...109,688,262

G

H

zinc finger homeobox 3

mRNA:increased expression:uterine cervix

RGD

NCBI chr16:72,782,885...73,891,930
Ensembl chr16:72,782,885...73,891,871

cervical adenocarcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

N

serine peptidase inhibitor Kazal type 1

NCBI chrNW_004624774:7,281,298...7,287,735
Ensembl chrNW_004624774:7,281,227...7,287,791

G

G

serine peptidase inhibitor Kazal type 1

NCBI chr23:50,365,686...50,373,300
Ensembl chr23:50,365,269...50,372,814

G

P

serine peptidase inhibitor Kazal type 1

NCBI chr 2:149,072,652...149,079,529
Ensembl chr 2:149,071,703...149,079,499

G

S

serine peptidase inhibitor Kazal type 1

NCBI chrNW_004936504:6,975,044...6,981,304
Ensembl chrNW_004936504:6,975,044...6,981,304

G

D

serine peptidase inhibitor Kazal type 1

NCBI chr 2:42,112,015...42,120,738
Ensembl chr 2:42,112,016...42,120,706

G

B

serine peptidase inhibitor Kazal type 1

NCBI chr 5:143,273,137...143,287,745

G

C

serine peptidase inhibitor Kazal type 1

NCBI chrNW_004955415:6,328,672...6,378,611
Ensembl chrNW_004955415:6,371,059...6,378,529

G

R

serine peptidase inhibitor, Kazal type 1

RGD

NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642

G

M

serine peptidase inhibitor, Kazal type 1

RGD

NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622

G

H

serine peptidase inhibitor Kazal type 1

RGD

NCBI chr 5:147,824,582...147,839,196
Ensembl chr 5:147,824,572...147,831,671

G

G

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

NCBI chr 2:86,239,101...86,244,491
Ensembl chr 2:86,239,105...86,243,795

G

P

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

NCBI chr13:205,687,558...205,691,512
Ensembl chr13:205,687,560...205,691,460

G

D

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

NCBI chr31:36,681,478...36,684,571
Ensembl chr31:36,681,357...36,695,665

G

B

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

NCBI chr21:28,669,323...28,673,556
Ensembl chr21:41,988,039...41,992,270

G

C

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

NCBI chrNW_004955407:39,363,693...39,365,724

G

R

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

RGD

NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597

G

M

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

RGD

NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251

G

H

trefoil factor 1

mRNA, protein:increased expression:uterine cervix

RGD

NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535

G

N

transferrin receptor

protein:increased expression:uterine cervix

NCBI chrNW_004624730:61,282,650...61,313,487
Ensembl chrNW_004624730:61,285,334...61,313,550

G

G

transferrin receptor

protein:increased expression:uterine cervix

NCBI chr15:91,102,153...91,134,994
Ensembl chr15:91,102,817...91,135,584

G

P

transferrin receptor

protein:increased expression:uterine cervix

NCBI chr13:133,976,765...133,997,554
Ensembl chr13:133,970,985...134,000,276

G

S

transferrin receptor

protein:increased expression:uterine cervix

NCBI chrNW_004936784:696,738...728,385
Ensembl chrNW_004936784:696,713...728,543

G

D

transferrin receptor

protein:increased expression:uterine cervix

NCBI chr33:29,206,024...29,237,221
Ensembl chr33:29,208,609...29,238,242

G

B

transferrin receptor

protein:increased expression:uterine cervix

NCBI chr 3:193,384,817...193,417,532
Ensembl chr 3:203,333,953...203,373,998

G

C

transferrin receptor

protein:increased expression:uterine cervix

NCBI chrNW_004955420:12,348,392...12,372,714
Ensembl chrNW_004955420:12,348,821...12,372,691

G

R

transferrin receptor

protein:increased expression:uterine cervix

RGD

NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257

G

M

transferrin receptor

protein:increased expression:uterine cervix

RGD

NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612

G

H

transferrin receptor

protein:increased expression:uterine cervix

RGD

NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153

G

N

tumor protein p53

disease_progression

NCBI chrNW_004624786:10,266,316...10,282,664
Ensembl chrNW_004624786:10,263,518...10,271,218

G

G

tumor protein p53

disease_progression

NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223

G

P

tumor protein p53

disease_progression

NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818

G

S

tumor protein p53

disease_progression

NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425

G

D

tumor protein p53

disease_progression

NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109

G

B

tumor protein p53

disease_progression

NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120

G

C

tumor protein p53

disease_progression

NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928

G

R

tumor protein p53

disease_progression

RGD

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

H

tumor protein p53

disease_progression

RGD

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

M

transformation related protein 53

disease_progression

RGD

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

cervical mucinous adenocarcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

N

serine/threonine kinase 11

disease_progression

DNA:mutations

NCBI chrNW_004624828:7,444,339...7,466,926
Ensembl chrNW_004624828:7,445,069...7,467,298

G

G

serine/threonine kinase 11

disease_progression

DNA:mutations

NCBI chr 6:973,033...996,857
Ensembl chr 6:974,144...995,136

G

P

serine/threonine kinase 11

disease_progression

DNA:mutations

NCBI chr 2:77,229,888...77,249,322
Ensembl chr 2:77,230,372...77,249,327

G

S

serine/threonine kinase 11

disease_progression

DNA:mutations

NCBI chrNW_004936588:579,816...601,033
Ensembl chrNW_004936588:579,816...603,654

G

D

serine/threonine kinase 11

disease_progression

DNA:mutations

NCBI chr20:57,558,966...57,579,163
Ensembl chr20:57,559,424...57,579,118

G

B

serine/threonine kinase 11

disease_progression

DNA:mutations

Ensembl chr19:1,188,537...1,210,677

G

C

serine/threonine kinase 11

disease_progression

DNA:mutations

NCBI chrNW_004955495:6,678,195...6,699,408
Ensembl chrNW_004955495:6,678,195...6,699,058

G

R

serine/threonine kinase 11

disease_progression

DNA:mutations

RGD

NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315

G

M

serine/threonine kinase 11

disease_progression

DNA:mutations

RGD

NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516

G

H

serine/threonine kinase 11

disease_progression

DNA:mutations

RGD

NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431

cervical squamous cell carcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

N

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

NCBI chrNW_004624885:2,783,058...2,839,688
Ensembl chrNW_004624885:2,812,448...2,839,693

G

G

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

NCBI chr20:9,194,611...9,241,102
Ensembl chr20:9,219,937...9,241,329

G

P

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

NCBI chr 4:95,154,230...95,197,308
Ensembl chr 4:95,154,358...95,197,304

G

S

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

NCBI chrNW_004936580:4,183,016...4,208,341
Ensembl chrNW_004936580:4,183,079...4,203,435

G

D

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

NCBI chr 7:42,762,021...42,785,192
Ensembl chr 7:42,748,136...42,782,999

G

B

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

NCBI chr 1:129,937,993...129,983,747

G

C

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

NCBI chrNW_004955545:1,078,319...1,106,938
Ensembl chrNW_004955545:1,078,319...1,106,938

G

R

adenosine deaminase, RNA-specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

RGD

NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282

G

M

adenosine deaminase, RNA-specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

RGD

NCBI chr 3:89,622,321...89,660,756
Ensembl chr 3:89,622,329...89,660,753

G

H

adenosine deaminase RNA specific

disease_progression

protein:increased expression:cervix squamous epithelium (human)

RGD

NCBI chr 1:154,582,057...154,627,997
Ensembl chr 1:154,581,695...154,628,013

G

N

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

NCBI chrNW_004624832:5,050,222...5,068,565
Ensembl chrNW_004624832:5,050,222...5,055,506

G

G

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

NCBI chr 6:42,186,028...42,193,105

G

P

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140

G

S

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820

G

D

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464

G

B

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468

G

C

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244

G

R

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

RGD

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

M

BCL2-associated X protein

protein:increased expression:uterine cervix

RGD

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

H

BCL2 associated X, apoptosis regulator

protein:increased expression:uterine cervix

RGD

NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798

G

N

baculoviral IAP repeat containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

NCBI chrNW_004624878:476,460...514,637

G

G

baculoviral IAP repeat containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

NCBI chr 1:93,721,449...93,746,638

G

S

baculoviral IAP repeat containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

NCBI chrNW_004936551:5,515,904...5,535,864

G

D

baculoviral IAP repeat containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

NCBI chr 5:29,294,080...29,314,837
Ensembl chr 5:29,294,692...29,312,771

G

B

baculoviral IAP repeat containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

NCBI chr11:97,298,736...97,324,966
Ensembl chr11:100,793,036...100,822,421

G

C

baculoviral IAP repeat containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

NCBI chrNW_004955412:5,658,322...5,685,628
Ensembl chrNW_004955412:5,659,478...5,685,114

G

R

baculoviral IAP repeat-containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

RGD

NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732

G

M

baculoviral IAP repeat-containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

RGD

NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065

G

H

baculoviral IAP repeat containing 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

RGD

NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670

G

N

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

NCBI chrNW_004624871:2,051,044...2,195,364
Ensembl chrNW_004624871:2,052,863...2,198,165

G

G

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

NCBI chr16:32,909,226...33,085,551
Ensembl chr16:32,910,693...33,082,587

G

P

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

NCBI chr12:36,498,138...36,639,847
Ensembl chr12:36,498,205...36,635,973

G

S

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

NCBI chrNW_004936490:3,001,445...3,139,538
Ensembl chrNW_004936490:3,003,484...3,137,479

G

D

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

NCBI chr 9:34,804,285...34,984,640
Ensembl chr 9:34,806,535...34,983,788

G

B

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

NCBI chr17:55,786,568...55,973,366
Ensembl chr17:60,901,073...61,083,462

G

C

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

NCBI chrNW_004955451:2,705,834...2,820,610
Ensembl chrNW_004955451:2,707,793...2,818,592

G

R

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

RGD

NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324

G

M

BRCA1 interacting protein C-terminal helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

RGD

NCBI chr11:85,948,957...86,092,041
Ensembl chr11:85,948,964...86,092,019

G

H

BRCA1 interacting helicase 1

severity

mRNA, protein:increased expression:uterine cervix, nucleus (human)

RGD

NCBI chr17:61,679,139...61,863,528
Ensembl chr17:61,679,139...61,863,559

G

N

C-C motif chemokine ligand 22

severity

NCBI chrNW_004624746:28,694,879...28,700,711
Ensembl chrNW_004624746:28,694,735...28,700,827

G

G

C-C motif chemokine ligand 22

severity

G

P

C-C motif chemokine ligand 22

severity

NCBI chr 6:19,296,726...19,301,506
Ensembl chr 6:19,296,637...19,302,737

G

S

C-C motif chemokine ligand 22

severity

NCBI chrNW_004936475:9,432,505...9,436,240
Ensembl chrNW_004936475:9,432,505...9,436,240

G

D

C-C motif chemokine ligand 22

severity

NCBI chr 2:59,039,650...59,045,519
Ensembl chr 2:59,040,539...59,045,625

G

B

C-C motif chemokine ligand 22

severity

NCBI chr16:37,631,861...37,640,208
Ensembl chr16:56,765,367...56,771,213

G

C

C-C motif chemokine ligand 22

severity

NCBI chrNW_004955433:15,002,001...15,007,324
Ensembl chrNW_004955433:15,001,930...15,008,032

G

R

C-C motif chemokine ligand 22

severity

RGD

NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400

G

M

C-C motif chemokine ligand 22

severity

RGD

NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327

G

H

C-C motif chemokine ligand 22

severity

RGD

NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189

G

N

C-C motif chemokine receptor 4

severity

NCBI chrNW_004624788:10,965,226...10,974,215
Ensembl chrNW_004624788:10,966,207...10,971,180

G

G

C-C motif chemokine receptor 4

severity

NCBI chr15:77,435,195...77,439,164
Ensembl chr15:77,437,265...77,438,347

G

P

C-C motif chemokine receptor 4

severity

NCBI chr13:18,860,596...18,865,987
Ensembl chr13:18,860,730...18,865,983

G

S

C-C motif chemokine receptor 4

severity

NCBI chrNW_004936473:23,321,167...23,323,075

G

D

C-C motif chemokine receptor 4

severity

NCBI chr23:3,844,072...3,847,770
Ensembl chr23:3,844,173...3,845,255

G

B

C-C motif chemokine receptor 4

severity

NCBI chr 3:32,882,419...32,887,442
Ensembl chr 3:33,188,482...33,189,564

G

C

C-C motif chemokine receptor 4

severity

NCBI chrNW_004955421:205,297...210,944
Ensembl chrNW_004955421:205,297...210,944

G

R

C-C motif chemokine receptor 4

severity

RGD

NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056

G

M

C-C motif chemokine receptor 4

severity

RGD

NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984

G

H

C-C motif chemokine receptor 4

severity

RGD

NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349

G

N

CD82 molecule

protein:decreased expression:uterine cervix

NCBI chrNW_004624767:3,556,128...3,589,956

G

G

CD82 molecule

protein:decreased expression:uterine cervix

NCBI chr 1:20,736,216...20,793,943
Ensembl chr 1:20,735,287...20,763,160

G

P

CD82 molecule

protein:decreased expression:uterine cervix

NCBI chr 2:17,751,153...17,803,172
Ensembl chr 2:17,750,660...17,803,126

G

S

CD82 molecule

protein:decreased expression:uterine cervix

G

D

CD82 molecule

protein:decreased expression:uterine cervix

NCBI chr18:44,658,414...44,707,897
Ensembl chr18:44,659,180...44,706,768

G

B

CD82 molecule

protein:decreased expression:uterine cervix

NCBI chr11:44,526,010...44,581,560
Ensembl chr11:45,020,319...45,075,876

G

C

CD82 molecule

protein:decreased expression:uterine cervix

NCBI chrNW_004955422:3,035,887...3,069,298
Ensembl chrNW_004955422:3,033,133...3,052,153

G

R

Cd82 molecule

protein:decreased expression:uterine cervix

RGD

NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809

G

M

CD82 antigen

protein:decreased expression:uterine cervix

RGD

NCBI chr 2:93,249,447...93,293,295
Ensembl chr 2:93,249,456...93,293,485

G

H

CD82 molecule

protein:decreased expression:uterine cervix

RGD

NCBI chr11:44,564,409...44,620,358
Ensembl chr11:44,564,427...44,620,358

G

N

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

NCBI chrNW_004624774:9,363,156...9,391,939
Ensembl chrNW_004624774:9,363,908...9,391,986

G

G

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

NCBI chr23:52,663,290...52,723,652
Ensembl chr23:52,664,076...52,697,304

G

P

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633

G

S

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

NCBI chrNW_004936504:4,898,947...4,927,195
Ensembl chrNW_004936504:4,898,945...4,928,923

G

D

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510

G

B

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

NCBI chr 5:145,478,725...145,537,858
Ensembl chr 5:151,483,572...151,517,415

G

C

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

NCBI chrNW_004955415:4,434,486...4,462,505
Ensembl chrNW_004955415:4,434,453...4,461,751

G

R

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

RGD

NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415

G

M

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

RGD

NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221

G

H

colony stimulating factor 1 receptor

protein:increased expression:uterine cervix

RGD

NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372

G

N

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

NCBI chrNW_004624731:10,413,715...10,468,660
Ensembl chrNW_004624731:10,413,645...10,468,690

G

G

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

NCBI chr26:33,802,349...33,867,743
Ensembl chr26:33,802,328...33,867,333

G

P

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

NCBI chr 1:122,215,878...122,278,705
Ensembl chr 1:122,215,882...122,277,750

G

S

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

NCBI chrNW_004936471:11,636,733...11,692,782
Ensembl chrNW_004936471:11,635,876...11,693,821

G

D

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

NCBI chr30:15,555,016...15,608,230
Ensembl chr30:15,555,266...15,606,521

G

B

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

NCBI chr15:28,378,339...28,442,800
Ensembl chr15:46,702,119...46,770,163

G

C

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

NCBI chrNW_004955409:4,633,542...4,686,768
Ensembl chrNW_004955409:4,632,858...4,686,860

G

R

fibroblast growth factor 7

cervical squamous cell carcinoma

RGD

NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929

G

M

fibroblast growth factor 7

cervical squamous cell carcinoma

RGD

NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105

G

H

fibroblast growth factor 7

cervical squamous cell carcinoma; mRNA:increased expression:cervical squamous cells

RGD

NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775

G

N

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

NCBI chrNW_004624755:25,633,690...25,647,361
Ensembl chrNW_004624755:25,635,165...25,646,932

G

G

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

NCBI chr27:46,958,444...46,974,032
Ensembl chr27:46,957,254...46,973,392

G

P

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

NCBI chr 8:879,151...894,968
Ensembl chr 8:879,159...894,964

G

S

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

NCBI chrNW_004936477:21,591,772...21,606,289
Ensembl chrNW_004936477:21,591,792...21,606,296

G

D

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

NCBI chr 3:62,309,128...62,318,932
Ensembl chr 3:62,303,756...62,323,896

G

B

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

NCBI chr 4:1,933,172...1,948,742
Ensembl chr 4:1,843,774...1,861,692

G

C

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

NCBI chrNW_004955514:1,030,244...1,038,590
Ensembl chrNW_004955514:1,025,600...1,038,590

G

R

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

RGD

NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341

G

M

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

RGD

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

H

fibroblast growth factor receptor 3

no_association

DNA:missense mutation:cds: p.S249G (human)

RGD

NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872

G

N

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

NCBI chrNW_004624734:26,424,053...26,427,431
Ensembl chrNW_004624734:26,423,079...26,427,732

G

G

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

NCBI chr24:52,497,465...52,501,161
Ensembl chr24:52,497,521...52,501,514

G

P

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554

G

S

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

NCBI chrNW_004936488:4,384,710...4,388,118
Ensembl chrNW_004936488:4,384,705...4,388,122

G

D

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

NCBI chr 8:48,330,856...48,334,273
Ensembl chr 8:48,331,026...48,333,467

G

B

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

NCBI chr14:55,832,570...55,835,984
Ensembl chr14:74,676,316...74,679,766

G

C

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

NCBI chrNW_004955523:307,181...310,728
Ensembl chrNW_004955523:305,728...310,728

G

R

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

RGD

NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036

G

M

FBJ osteosarcoma oncogene

disease_progression

protein:increased expression:uterine cervix

RGD

NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047

G

H

Fos proto-oncogene, AP-1 transcription factor subunit

disease_progression

protein:increased expression:uterine cervix

RGD

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230

G

N

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

NCBI chrNW_004624767:20,519,054...20,525,311
Ensembl chrNW_004624767:20,519,313...20,524,554

G

G

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

NCBI chr 1:8,356,263...8,365,606
Ensembl chr 1:8,356,836...8,364,918

G

P

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

NCBI chr 2:6,430,158...6,436,173
Ensembl chr 2:6,430,153...6,436,173

G

S

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

NCBI chrNW_004936599:3,642,504...3,649,294
Ensembl chrNW_004936599:3,642,504...3,648,417

G

D

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

NCBI chr18:51,366,719...51,374,411
Ensembl chr18:51,368,352...51,373,748

G

B

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

NCBI chr11:61,252,513...61,261,032
Ensembl chr11:64,581,841...64,589,304

G

C

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

NCBI chrNW_004955422:19,425,741...19,431,801
Ensembl chrNW_004955422:19,423,591...19,433,885

G

R

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

RGD

NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930

G

M

fos-like antigen 1

protein:decreased expression:uterine cervix

RGD

NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974

G

H

FOS like 1, AP-1 transcription factor subunit

protein:decreased expression:uterine cervix

RGD

NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573

G

N

forkhead box P3

severity

NCBI chrNW_004624893:995,145...1,008,492
Ensembl chrNW_004624893:995,182...1,008,679

G

G

forkhead box P3

severity

NCBI chr X:46,349,890...46,365,133

G

P

forkhead box P3

severity

NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968

G

S

forkhead box P3

severity

NCBI chrNW_004936721:1,118,376...1,125,282
Ensembl chrNW_004936721:1,118,782...1,132,308

G

D

forkhead box P3

severity

NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758

G

B

forkhead box P3

severity

NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029

G

C

forkhead box P3

severity

NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606

G

R

forkhead box P3

severity

RGD

NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838

G

M

forkhead box P3

severity

RGD

NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484

G

H

forkhead box P3

severity

RGD

NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800

G

P

baculoviral IAP repeat-containing protein 2

disease_progression

DNA, protein:amplification, increased expression:uterine cervix, nucleus

NCBI chr 9:33,041,592...33,062,865
Ensembl chr 9:33,041,663...33,062,854

G

P

microRNA mir-21

RNA:increased expression:cervical cell

NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358

G

D

microRNA mir-21

RNA:increased expression:cervical cell

NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624

G

R

microRNA 21

RNA:increased expression:cervical cell

RGD

NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348

G

H

microRNA 21

RNA:increased expression:cervical cell

RGD

NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337

G

M

microRNA 21a

RNA:increased expression:cervical cell

RGD

NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984

G

P

microRNA mir-31

RNA:increased expression:blood serum (human)

NCBI chr 1:201,198,732...201,198,809
Ensembl chr 1:201,198,732...201,198,809

G

D

microRNA mir-31

RNA:increased expression:blood serum (human)

NCBI chr11:40,904,438...40,904,496
Ensembl chr11:40,904,437...40,904,503

G

R

microRNA 31

RNA:increased expression:blood serum (human)

RGD

NCBI chr 5:103,599,038...103,599,143

G

M

microRNA 31

RNA:increased expression:blood serum (human)

RGD

NCBI chr 4:88,828,794...88,828,899
Ensembl chr 4:88,828,794...88,828,899

G

H

microRNA 31

RNA:increased expression:blood serum (human)

RGD

NCBI chr 9:21,512,115...21,512,185
Ensembl chr 9:21,512,115...21,512,185

G

N

podoplanin

disease_progression

NCBI chrNW_004624764:163,370...192,770

G

G

podoplanin

disease_progression

NCBI chr20:118,644,060...118,679,508
Ensembl chr20:118,644,051...118,679,311

G

P

podoplanin

disease_progression

NCBI chr 6:73,019,063...73,050,000
Ensembl chr 6:73,019,057...73,049,996

G

S

podoplanin

disease_progression

NCBI chrNW_004936474:1,751,159...1,779,011
Ensembl chrNW_004936474:1,750,944...1,781,156

G

D

podoplanin

disease_progression

NCBI chr 2:83,552,735...83,581,375
Ensembl chr 2:83,552,830...83,581,375

G

B

podoplanin

disease_progression

NCBI chr 1:12,728,569...12,759,781
Ensembl chr 1:13,728,233...13,759,584

G

C

podoplanin

disease_progression

NCBI chrNW_004955527:4,183,639...4,215,200

G

R

podoplanin

disease_progression

RGD

NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656

G

M

podoplanin

disease_progression

RGD

NCBI chr 4:142,993,979...143,026,134
Ensembl chr 4:142,994,001...143,026,134

G

H

podoplanin

disease_progression

RGD

NCBI chr 1:13,583,757...13,617,957
Ensembl chr 1:13,583,465...13,617,957

G

N

SMAD family member 3

severity

NCBI chrNW_004624781:5,795,652...5,890,047
Ensembl chrNW_004624781:5,795,652...5,890,371

G

G

SMAD family member 3

severity

NCBI chr26:16,319,959...16,446,472
Ensembl chr26:16,320,933...16,446,527

G

P

SMAD family member 3

severity

NCBI chr 1:164,998,457...165,124,455
Ensembl chr 1:164,998,103...165,124,449

G

S

SMAD family member 3

severity

NCBI chrNW_004936471:27,080,662...27,185,861
Ensembl chrNW_004936471:27,080,575...27,189,793

G

D

SMAD family member 3

severity

NCBI chr30:31,246,313...31,360,098
Ensembl chr30:31,245,657...31,363,337

G

B

SMAD family member 3

severity

NCBI chr15:46,013,764...46,143,126
Ensembl chr15:64,284,949...64,414,185

G

C

SMAD family member 3

severity

NCBI chrNW_004955450:8,747,651...8,842,003
Ensembl chrNW_004955450:8,747,651...8,842,136

G

R

SMAD family member 3

severity

RGD

NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960

G

M

SMAD family member 3

severity

RGD

NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276

G

H

SMAD family member 3

severity

RGD

NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173

G

N

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

NCBI chrNW_004624801:8,228,618...8,270,606
Ensembl chrNW_004624801:8,228,357...8,270,982

G

G

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

NCBI chr16:70,819,591...70,850,471
Ensembl chr16:70,819,139...70,850,471

G

P

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

NCBI chr12:3,254,794...3,300,835
Ensembl chr12:3,254,493...3,300,834

G

S

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

NCBI chrNW_004936594:3,232,433...3,244,241
Ensembl chrNW_004936594:3,232,355...3,244,241

G

D

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

NCBI chr 9:2,521,882...2,533,883
Ensembl chr 9:2,521,882...2,533,989

G

B

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

NCBI chr17:72,928,692...73,001,892
Ensembl chr17:78,476,807...78,495,649

G

C

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

NCBI chrNW_004955506:3,769,113...3,812,896
Ensembl chrNW_004955506:3,768,646...3,813,820

G

R

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

RGD

NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611

G

M

tissue inhibitor of metalloproteinase 2

protein:decreased expression:uterine cervix

RGD

NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566

G

H

TIMP metallopeptidase inhibitor 2

protein:decreased expression:uterine cervix

RGD

NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387

G

N

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

NCBI chrNW_004624816:2,519,839...2,540,766

G

G

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr11:45,976,689...46,001,021
Ensembl chr11:45,976,700...46,001,457

G

P

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr 5:15,674,028...15,692,944
Ensembl chr 5:15,674,057...15,692,936

G

S

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

NCBI chrNW_004936512:7,427,926...7,448,700
Ensembl chrNW_004936512:7,427,729...7,449,078

G

D

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr27:4,921,606...4,944,830
Ensembl chr27:4,921,606...4,944,783

G

B

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

NCBI chr12:38,986,844...39,010,307
Ensembl chr12:39,879,951...39,902,303

G

C

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

NCBI chrNW_004955547:335,344...358,503
Ensembl chrNW_004955547:335,275...358,503

G

R

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

RGD

NCBI chr 7:130,527,313...130,542,567
Ensembl chr 7:130,527,316...130,543,633

G

M

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

RGD

NCBI chr15:99,290,828...99,307,930
Ensembl chr15:99,290,763...99,307,930

G

H

transmembrane BAX inhibitor motif containing 6

disease_progression

mRNA:increased expression:uterine cervix

RGD

NCBI chr12:49,741,557...49,764,934
Ensembl chr12:49,707,725...49,764,934

G

N

TNF receptor superfamily member 4

severity

NCBI chrNW_004624818:8,372,092...8,376,108
Ensembl chrNW_004624818:8,373,810...8,376,204

G

G

TNF receptor superfamily member 4

severity

NCBI chr20:130,231,064...130,234,525
Ensembl chr20:130,231,584...130,234,313

G

P

TNF receptor superfamily member 4

severity

NCBI chr 6:63,523,850...63,526,672
Ensembl chr 6:63,523,804...63,526,666

G

S

TNF receptor superfamily member 4

severity

NCBI chrNW_004936737:1,901,749...1,904,382

G

D

TNF receptor superfamily member 4

severity

NCBI chr 5:56,401,410...56,404,410
Ensembl chr 5:56,401,384...56,404,761

G

B

TNF receptor superfamily member 4

severity

Ensembl chr 1:1,168,935...1,171,337

G

C

TNF receptor superfamily member 4

severity

NCBI chrNW_004955486:9,565,424...9,569,836
Ensembl chrNW_004955486:9,567,220...9,569,676

G

R

TNF receptor superfamily member 4

severity

RGD

NCBI chr 5:166,606,909...166,609,599
Ensembl chr 5:166,606,909...166,609,599

G

M

tumor necrosis factor receptor superfamily, member 4

severity

RGD

NCBI chr 4:156,098,049...156,101,070
Ensembl chr 4:156,098,300...156,101,069

G

H

TNF receptor superfamily member 4

severity

RGD

NCBI chr 1:1,211,340...1,214,153
Ensembl chr 1:1,211,326...1,214,153

G

N

TNF superfamily member 4

severity

NCBI chrNW_004624771:8,580,489...8,599,735

G

G

TNF superfamily member 4

severity

NCBI chr25:55,714,291...55,998,009
Ensembl chr25:55,974,691...55,997,374

G

P

TNF superfamily member 4

severity

NCBI chr 9:115,535,185...115,857,457
Ensembl chr 9:115,550,569...115,659,263

G

S

TNF superfamily member 4

severity

NCBI chrNW_004936481:14,391,359...14,409,514

G

D

TNF superfamily member 4

severity

NCBI chr 7:25,883,297...25,909,608
Ensembl chr 7:25,883,251...25,906,892

G

B

TNF superfamily member 4

severity

NCBI chr 1:148,684,689...148,989,775
Ensembl chr 1:152,391,450...152,415,845
Ensembl chr 1:152,391,450...152,415,845

G

C

TNF superfamily member 4

severity

NCBI chrNW_004955406:13,477,077...13,493,309
Ensembl chrNW_004955406:13,477,077...13,493,309

G

R

TNF superfamily member 4

severity

RGD

NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788

G

M

tumor necrosis factor (ligand) superfamily, member 4

severity

RGD

NCBI chr 1:161,223,009...161,245,777
Ensembl chr 1:161,222,980...161,245,981

G

H

TNF superfamily member 4

severity

RGD

NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,183,731...173,207,331

G

N

tumor protein p53

disease_progression

NCBI chrNW_004624786:10,266,316...10,282,664
Ensembl chrNW_004624786:10,263,518...10,271,218

G

G

tumor protein p53

disease_progression

NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223

G

P

tumor protein p53

disease_progression

NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818

G

S

tumor protein p53

disease_progression

NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425

G

D

tumor protein p53

disease_progression

NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109

G

B

tumor protein p53

disease_progression

NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120

G

C

tumor protein p53

disease_progression

NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928

G

R

tumor protein p53

disease_progression

RGD

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

H

tumor protein p53

disease_progression

RGD

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

M

transformation related protein 53

disease_progression

RGD

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

N

thymidine phosphorylase

disease_progression

NCBI chrNW_004624752:251,670...256,243
Ensembl chrNW_004624752:252,937...256,244

G

G

thymidine phosphorylase

disease_progression

NCBI chr19:32,997,337...33,001,558
Ensembl chr19:32,997,304...33,001,215

G

S

thymidine phosphorylase

disease_progression

NCBI chrNW_004936629:315,609...320,356
Ensembl chrNW_004936629:315,610...319,076

G

B

thymidine phosphorylase

disease_progression

NCBI chr22:30,772,088...30,776,618

G

C

thymidine phosphorylase

disease_progression

NCBI chrNW_004955413:33,505,424...33,509,095
Ensembl chrNW_004955413:33,505,446...33,508,748

G

R

thymidine phosphorylase

disease_progression

RGD

NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874
Ensembl chr 7:120,438,770...120,443,874

G

M

thymidine phosphorylase

disease_progression

RGD

NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242

G

H

thymidine phosphorylase

disease_progression

RGD

NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032

cervix carcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

N

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chrNW_004624825:4,711,921...4,714,926
Ensembl chrNW_004624825:4,708,093...4,714,921

G

G

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chr29:20,978,878...20,981,393

G

P

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chr 7:78,451,845...78,454,938
Ensembl chr 7:78,451,851...78,454,938

G

S

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chrNW_004936877:666,545...669,351
Ensembl chrNW_004936877:666,523...669,338

G

D

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chr15:17,786,808...17,789,422
Ensembl chr15:17,786,357...17,789,422

G

B

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chr14:1,329,745...1,332,315
Ensembl chr14:19,381,911...19,384,542

G

C

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chrNW_004955550:1,273,170...1,275,843
Ensembl chrNW_004955550:1,273,284...1,279,743

G

R

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785

G

M

apurinic/apyrimidinic endonuclease 1

DNA:SNPs (human)

NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596

G

H

apurinic/apyrimidinic endodeoxyribonuclease 1

DNA:SNPs (human)

RGD

NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772

G

N

BAG cochaperone 1

protein:increased expression:uterine cervix

NCBI chrNW_004624736:38,015,150...38,025,079
Ensembl chrNW_004624736:38,015,044...38,025,079

G

G

BAG cochaperone 1

protein:increased expression:uterine cervix

NCBI chr12:47,006,177...47,016,177

G

P

BAG cochaperone 1

protein:increased expression:uterine cervix

NCBI chr10:33,227,530...33,240,731
Ensembl chr10:33,227,338...33,240,724

G

S

BAG cochaperone 1

protein:increased expression:uterine cervix

NCBI chrNW_004936524:1,793,001...1,804,145
Ensembl chrNW_004936524:1,791,119...1,804,151

G

D

BAG cochaperone 1

protein:increased expression:uterine cervix

NCBI chr11:50,348,833...50,363,532
Ensembl chr11:50,350,999...50,363,581

G

B

BAG cochaperone 1

protein:increased expression:uterine cervix

NCBI chr 9:33,033,267...33,043,013
Ensembl chr 9:33,841,449...33,851,167

G

C

BAG cochaperone 1

protein:increased expression:uterine cervix

NCBI chrNW_004955472:2,394,317...2,405,199

G

R

BAG cochaperone 1

protein:increased expression:uterine cervix

RGD

NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075

G

M

BCL2-associated athanogene 1

protein:increased expression:uterine cervix

RGD

NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294

G

H

BAG cochaperone 1

protein:increased expression:uterine cervix

RGD

NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720

G

N

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

NCBI chrNW_004624754:23,297,077...23,302,366
Ensembl chrNW_004624754:23,296,800...23,301,223

G

G

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

NCBI chr17:38,492,776...38,502,534
Ensembl chr17:38,492,858...38,501,281

G

P

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

NCBI chr 7:29,808,849...29,815,345

G

S

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

NCBI chrNW_004936476:25,347,608...25,354,772
Ensembl chrNW_004936476:25,347,545...25,355,789

G

D

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

NCBI chr12:2,950,359...2,957,604
Ensembl chr12:2,948,364...2,957,018

G

B

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

NCBI chr 6:33,146,998...33,154,755
Ensembl chr 6:34,255,769...34,263,211

G

C

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

NCBI chrNW_004955437:2,036,415...2,041,997
Ensembl chrNW_004955437:2,036,415...2,041,997

G

R

BCL2-antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

RGD

NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264

G

M

BCL2-antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

RGD

NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983

G

H

BCL2 antagonist/killer 1

DNA:missense mutations:exon:multiple (human)

RGD

NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293

G

N

cyclin D3

NCBI chrNW_004624754:17,148,108...17,194,626
Ensembl chrNW_004624754:17,148,076...17,194,000

G

G

cyclin D3

NCBI chr17:30,107,236...30,228,449
Ensembl chr17:30,221,598...30,227,452

G

P

cyclin D3

NCBI chr 7:37,087,336...37,182,462
Ensembl chr 7:37,082,097...37,181,366

G

S

cyclin D3

NCBI chrNW_004936476:17,799,754...17,886,835
Ensembl chrNW_004936476:17,879,869...17,886,827

G

D

cyclin D3

NCBI chr12:10,593,786...10,688,304
Ensembl chr12:10,594,712...10,600,891

G

B

cyclin D3

NCBI chr 6:41,518,421...41,630,103
Ensembl chr 6:42,820,569...42,827,498

G

C

cyclin D3

NCBI chrNW_004955437:8,266,523...8,273,855
Ensembl chrNW_004955437:8,268,118...8,273,855

G

R

cyclin D3

RGD

NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371

G

M

cyclin D3

RGD

NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616

G

H

cyclin D3

RGD

NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357

G

N

CD9 molecule

disease_progression

NCBI chrNW_004624860:3,027,126...3,055,974
Ensembl chrNW_004624860:3,027,029...3,056,798

G

G

CD9 molecule

disease_progression

NCBI chr11:6,236,449...6,275,904
Ensembl chr11:6,236,494...6,275,909

G

P

CD9 molecule

disease_progression

NCBI chr 5:64,420,177...64,459,783
Ensembl chr 5:64,420,182...64,460,304

G

S

CD9 molecule

disease_progression

NCBI chrNW_004936709:1,497,504...1,530,114

G

D

CD9 molecule

disease_progression

NCBI chr27:38,742,539...38,754,984
Ensembl chr27:38,742,963...38,774,576

G

B

CD9 molecule

disease_progression

NCBI chr12:6,327,783...6,366,083
Ensembl chr12:6,245,348...6,283,385

G

C

CD9 molecule

disease_progression

NCBI chrNW_004955413:3,891,874...3,924,065
Ensembl chrNW_004955413:3,891,874...3,928,119

G

R

CD9 molecule

disease_progression

RGD

NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222

G

M

CD9 antigen

disease_progression

RGD

NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754

G

H

CD9 molecule

disease_progression

RGD

NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271

G

N

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

NCBI chrNW_004624767:20,559,801...20,566,326
Ensembl chrNW_004624767:20,559,795...20,566,341

G

G

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

NCBI chr 1:8,384,212...8,391,501
Ensembl chr 1:8,385,020...8,390,889

G

P

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

NCBI chr 2:6,455,155...6,463,493
Ensembl chr 2:6,450,332...6,463,486

G

S

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

NCBI chrNW_004936599:3,663,288...3,670,048
Ensembl chrNW_004936599:3,663,326...3,670,047

G

D

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

NCBI chr18:51,389,797...51,396,109
Ensembl chr18:51,389,824...51,396,107

G

B

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

NCBI chr11:61,226,755...61,233,181
Ensembl chr11:64,555,877...64,561,950

G

C

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

NCBI chrNW_004955422:19,463,090...19,470,605
Ensembl chrNW_004955422:19,463,987...19,470,605

G

R

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

RGD

NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414

G

M

epidermal growth factor-containing fibulin-like extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

RGD

NCBI chr19:5,523,974...5,532,548
Ensembl chr19:5,523,982...5,532,545

G

H

EGF containing fibulin extracellular matrix protein 2

exacerbates

mRNA, protein:increased expression:cervix epithelium (human)

RGD

NCBI chr11:65,866,441...65,872,800
Ensembl chr11:65,866,441...65,873,592

G

N

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

NCBI chrNW_004624743:15,407,217...15,442,610
Ensembl chrNW_004624743:15,408,485...15,431,967

G

G

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

NCBI chr 4:90,591,198...90,642,331
Ensembl chr 4:90,600,690...90,637,563

G

P

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

NCBI chr 2:103,378,428...103,415,066
Ensembl chr 2:103,378,429...103,408,759

G

S

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

NCBI chrNW_004936523:6,661,119...6,686,988
Ensembl chrNW_004936523:6,661,315...6,690,425

G

D

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

NCBI chr 3:12,879,823...12,920,710
Ensembl chr 3:12,879,477...12,919,634

G

B

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

NCBI chr 5:92,061,414...92,119,087
Ensembl chr 5:97,641,353...97,668,365

G

C

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

NCBI chrNW_004955418:15,827,560...15,859,720
Ensembl chrNW_004955418:15,830,371...15,859,720

G

R

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

RGD

NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447

G

M

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

RGD

NCBI chr13:74,787,692...74,841,321
Ensembl chr13:74,787,687...74,841,320

G

H

endoplasmic reticulum aminopeptidase 1

DNA:SNPs (human)

RGD

NCBI chr 5:96,760,813...96,935,854
Ensembl chr 5:96,760,810...96,808,100

G

N

fibroblast growth factor receptor 3

DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia
DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported

PMID:10471491 PMID:11114733

RGD:2289864 RGD:2289865

NCBI chrNW_004624755:25,633,690...25,647,361
Ensembl chrNW_004624755:25,635,165...25,646,932

G

G

fibroblast growth factor receptor 3

DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia
DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported

PMID:10471491 PMID:11114733

RGD:2289864 RGD:2289865

NCBI chr27:46,958,444...46,974,032
Ensembl chr27:46,957,254...46,973,392

G

P

fibroblast growth factor receptor 3

DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported
DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia

PMID:10471491 PMID:11114733

RGD:2289864 RGD:2289865

NCBI chr 8:879,151...894,968
Ensembl chr 8:879,159...894,964

G

S

fibroblast growth factor receptor 3

DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported
DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia

PMID:10471491 PMID:11114733

RGD:2289864 RGD:2289865

NCBI chrNW_004936477:21,591,772...21,606,289
Ensembl chrNW_004936477:21,591,792...21,606,296

G

D

fibroblast growth factor receptor 3

DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia
DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported

PMID:10471491 PMID:11114733

RGD:2289864 RGD:2289865

NCBI chr 3:62,309,128...62,318,932
Ensembl chr 3:62,303,756...62,323,896

G

B

fibroblast growth factor receptor 3

DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia
DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported

PMID:10471491 PMID:11114733

RGD:2289864 RGD:2289865

NCBI chr 4:1,933,172...1,948,742
Ensembl chr 4:1,843,774...1,861,692

G

C

fibroblast growth factor receptor 3

DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported
DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia

PMID:10471491 PMID:11114733

RGD:2289864 RGD:2289865

NCBI chrNW_004955514:1,030,244...1,038,590
Ensembl chrNW_004955514:1,025,600...1,038,590

G

R

fibroblast growth factor receptor 3

RGD

NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341

G

M

fibroblast growth factor receptor 3

RGD

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

H

fibroblast growth factor receptor 3

DNA:missense mutations:CDS:somatic mutations found in 3/12 (25%) of cervix carcinomas, all mutations are equivalent to activating germline mutations which cause thanatophoric dysplasia
DNA:missense mutation:CDS:amino acid S249C, only found in 1/51 primary tumors and no cell lines tested implying that mutation frequency is much lower than previously reported

RGD

PMID:10471491 PMID:11114733

RGD:2289864, RGD:2289865

NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872

G

B

glutathione S-transferase mu 1

onset

associated with Papillomavirus Infections;DNA:deletion:cds (human)

Ensembl chr 1:127,979,238...128,010,411

G

R

glutathione S-transferase mu 1

onset

associated with Papillomavirus Infections;DNA:deletion:cds (human)

RGD

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

M

glutathione S-transferase, mu 1

onset

associated with Papillomavirus Infections;DNA:deletion:cds (human)

RGD

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

H

glutathione S-transferase mu 1

onset

associated with Papillomavirus Infections;DNA:deletion:cds (human)

RGD

NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039

G

R

glutathione S-transferase theta 1

susceptibility

DNA:deletion:cds (human)

RGD

NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585

G

M

glutathione S-transferase, theta 1

susceptibility

DNA:deletion:cds (human)

RGD

NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418

G

H

glutathione S-transferase theta 1

susceptibility

DNA:deletion:cds (human)

RGD

G

R

H19 imprinted maternally expressed transcript

mRNA:decreased expression:uterine cervix

NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134

G

M

H19, imprinted maternally expressed transcript

mRNA:decreased expression:uterine cervix

RGD

NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,131,917

G

H

H19 imprinted maternally expressed transcript

mRNA:decreased expression:uterine cervix

RGD

NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,004,552

G

G

glutathione S-transferase Mu 1

onset

associated with Papillomavirus Infections;DNA:deletion:cds (human)

NCBI chr20:23,854,969...23,861,634

G

N

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

NCBI chrNW_004624737:17,271,881...17,619,123
Ensembl chrNW_004624737:17,271,992...17,528,889

G

G

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

NCBI chr 9:122,089,768...122,376,320

G

P

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

NCBI chr14:138,502,005...138,771,543
Ensembl chr14:138,499,309...138,771,540

G

S

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

NCBI chrNW_004936486:16,744,607...16,923,209
Ensembl chrNW_004936486:16,744,570...16,923,543

G

D

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

NCBI chr28:38,204,611...38,427,482
Ensembl chr28:38,204,610...38,427,380

G

B

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

NCBI chr10:126,059,701...126,365,850
Ensembl chr10:130,305,485...130,609,422

G

C

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

NCBI chrNW_004955477:7,103,035...7,375,073
Ensembl chrNW_004955477:7,102,977...7,376,530

G

R

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

RGD

NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756

G

M

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

RGD

NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995

G

H

O-6-methylguanine-DNA methyltransferase

DNA:polymorphisms:cds:p.I143V, p.K178R (human)

RGD

NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983

G

N

prostaglandin-endoperoxide synthase 1

disease_progression

NCBI chrNW_004624760:12,917,244...12,937,858
Ensembl chrNW_004624760:12,915,206...12,937,824

G

G

prostaglandin-endoperoxide synthase 1

disease_progression

NCBI chr12:17,195,403...17,218,450
Ensembl chr12:17,192,628...17,218,315

G

P

prostaglandin-endoperoxide synthase 1

disease_progression

NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035

G

S

prostaglandin-endoperoxide synthase 1

disease_progression

NCBI chrNW_004936487:10,745,465...10,758,812
Ensembl chrNW_004936487:10,745,327...10,758,823

G

D

prostaglandin-endoperoxide synthase 1

disease_progression

NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819

G

B

prostaglandin-endoperoxide synthase 1

disease_progression

NCBI chr 9:93,495,365...93,517,557
Ensembl chr 9:121,837,095...121,859,283

G

C

prostaglandin-endoperoxide synthase 1

disease_progression

NCBI chrNW_004955419:5,678,750...5,699,305
Ensembl chrNW_004955419:5,678,694...5,699,305

G

R

prostaglandin-endoperoxide synthase 1

disease_progression

RGD

NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586

G

M

prostaglandin-endoperoxide synthase 1

disease_progression

RGD

NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284

G

H

prostaglandin-endoperoxide synthase 1

disease_progression

RGD

NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703

G

N

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

NCBI chrNW_004624735:15,356,911...15,713,219
Ensembl chrNW_004624735:15,461,178...15,714,071

G

G

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

NCBI chr 8:134,897,511...135,246,300

G

P

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054

G

S

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

NCBI chrNW_004936470:10,379,855...10,578,531
Ensembl chrNW_004936470:10,379,872...10,578,543

G

D

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

NCBI chr13:35,302,439...35,541,336
Ensembl chr13:35,303,380...35,541,294

G

B

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

NCBI chr 8:137,330,777...137,677,306
Ensembl chr 8:140,412,773...140,684,898

G

C

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

NCBI chrNW_004955461:14,337,914...14,622,779
Ensembl chrNW_004955461:14,337,914...14,556,931

G

R

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

RGD

NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783

G

M

PTK2 protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

RGD

NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129

G

H

protein tyrosine kinase 2

protein:increased tyrosine phosphorylation:cervix

RGD

NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216

G

N

secreted protein acidic and cysteine rich

DNA:hypermethylation

NCBI chrNW_004624733:37,348,993...37,369,804
Ensembl chrNW_004624733:37,338,284...37,369,804

G

G

secreted protein acidic and cysteine rich

DNA:hypermethylation

NCBI chr23:54,224,003...54,248,869
Ensembl chr23:54,222,838...54,238,006

G

P

secreted protein acidic and cysteine rich

DNA:hypermethylation

NCBI chr16:71,368,164...71,380,972
Ensembl chr16:71,357,586...71,381,161

G

S

secreted protein acidic and cysteine rich

DNA:hypermethylation

NCBI chrNW_004936515:11,026,156...11,046,812
Ensembl chrNW_004936515:11,025,724...11,046,849

G

D

secreted protein acidic and cysteine rich

DNA:hypermethylation

NCBI chr 4:57,659,541...57,682,147
Ensembl chr 4:57,659,650...57,681,711

G

B

secreted protein acidic and cysteine rich

DNA:hypermethylation

NCBI chr 5:147,087,903...147,112,466
Ensembl chr 5:153,090,181...153,115,750

G

C

secreted protein acidic and cysteine rich

DNA:hypermethylation

NCBI chrNW_004955408:6,100,123...6,122,460
Ensembl chrNW_004955408:6,099,003...6,122,459

G

R

secreted protein acidic and cysteine rich

DNA:hypermethylation

RGD

NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396

G

M

secreted acidic cysteine rich glycoprotein

DNA:hypermethylation

RGD

NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009

G

H

secreted protein acidic and cysteine rich

DNA:hypermethylation

RGD

NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975

G

N

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

NCBI chrNW_004624754:23,827,782...23,845,690
Ensembl chrNW_004624754:23,827,706...23,837,356

G

G

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

NCBI chr17:39,266,870...39,277,658

G

P

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

NCBI chr 7:25,045,085...25,056,915
Ensembl chr 7:25,045,685...25,056,300

G

S

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

NCBI chrNW_004936476:25,913,699...25,923,419
Ensembl chrNW_004936476:25,913,663...25,923,427

G

D

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

NCBI chr12:2,407,512...2,417,469
Ensembl chr12:2,378,126...2,432,303

G

B

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

NCBI chr 6:32,394,586...32,408,297
Ensembl chr 6:33,507,332...33,523,750

G

C

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

NCBI chrNW_004955437:1,480,217...1,499,032
Ensembl chrNW_004955437:1,477,341...1,498,575

G

R

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

RGD

NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407

G

M

transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)

susceptibility

DNA:SNP: :(rs4148876)(human)

RGD

NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295

G

H

transporter 2, ATP binding cassette subfamily B member

susceptibility

DNA:SNP: :(rs4148876)(human)

RGD

NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739

G

N

thymidine kinase 1

protein:increased expression:serum (human)

NCBI chrNW_004624801:7,685,003...7,692,949
Ensembl chrNW_004624801:7,685,017...7,692,872

G

G

thymidine kinase 1

protein:increased expression:serum (human)

NCBI chr16:70,186,103...70,200,689
Ensembl chr16:70,186,767...70,200,610

G

P

thymidine kinase 1

protein:increased expression:serum (human)

NCBI chr12:3,785,997...3,794,824
Ensembl chr12:3,786,031...3,795,917

G

S

thymidine kinase 1

protein:increased expression:serum (human)

NCBI chrNW_004936594:2,784,891...2,794,693
Ensembl chrNW_004936594:2,784,226...2,794,830

G

D

thymidine kinase 1

protein:increased expression:serum (human)

NCBI chr 9:2,959,450...2,970,908
Ensembl chr 9:2,959,488...2,971,064

G

B

thymidine kinase 1

protein:increased expression:serum (human)

NCBI chr17:72,251,416...72,265,308
Ensembl chr17:77,803,749...77,816,747

G

C

thymidine kinase 1

protein:increased expression:serum (human)

NCBI chrNW_004955506:4,379,830...4,390,729
Ensembl chrNW_004955506:4,379,830...4,394,713

G

R

thymidine kinase 1

protein:increased expression:serum (human)

RGD

NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920

G

M

thymidine kinase 1

protein:increased expression:serum (human)

RGD

NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918

G

H

thymidine kinase 1

protein:increased expression:serum (human)

RGD

NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233

G

N

tumor susceptibility 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

PMID:10505033 PMID:10600297

RGD:2291851 RGD:2291852

NCBI chrNW_004624766:9,932,190...9,977,725
Ensembl chrNW_004624766:9,934,228...9,977,697

G

G

tumor susceptibility 101

mRNA:alternative forms:uterine cervix:multiple
mRNA:alternative form:uterine cervix

PMID:10505033 PMID:10600297

RGD:2291851 RGD:2291852

NCBI chr 1:46,401,889...46,451,122
Ensembl chr 1:46,402,024...46,450,916

G

P

tumor susceptibility 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

PMID:10505033 PMID:10600297

RGD:2291851 RGD:2291852

NCBI chr 2:40,673,187...40,720,681

G

S

tumor susceptibility 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

PMID:10505033 PMID:10600297

RGD:2291851 RGD:2291852

NCBI chrNW_004936590:61,352...62,037

G

D

tumor susceptibility 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

PMID:10505033 PMID:10600297

RGD:2291851 RGD:2291852

NCBI chr21:40,910,870...40,952,922
Ensembl chr21:40,910,874...40,952,808

G

B

tumor susceptibility 101

mRNA:alternative forms:uterine cervix:multiple
mRNA:alternative form:uterine cervix

PMID:10505033 PMID:10600297

RGD:2291851 RGD:2291852

NCBI chr11:18,518,110...18,564,814
Ensembl chr11:18,189,868...18,248,149

G

C

tumor susceptibility 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

PMID:10505033 PMID:10600297

RGD:2291851 RGD:2291852

NCBI chrNW_004955414:33,154,812...33,193,769
Ensembl chrNW_004955414:33,154,812...33,193,769

G

R

tumor susceptibility 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

RGD

PMID:10600297 PMID:10505033

RGD:2291851, RGD:2291852

NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554

G

M

tumor susceptibility gene 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

RGD

PMID:10600297 PMID:10505033

RGD:2291851, RGD:2291852

NCBI chr 7:46,538,693...46,569,716
Ensembl chr 7:46,538,697...46,569,717

G

H

tumor susceptibility 101

mRNA:alternative form:uterine cervix
mRNA:alternative forms:uterine cervix:multiple

RGD

PMID:10600297 PMID:10505033

RGD:2291851, RGD:2291852

NCBI chr11:18,480,311...18,526,942
Ensembl chr11:18,468,336...18,526,951

Term paths to the root

Path 1
Term	Annotations
disease	199753
disease of anatomical entity	168001
reproductive system disease	29713
reproductive organ cancer	12332
female reproductive organ cancer	6196
uterine cancer	3088
cervical cancer	924
cervical alveolar soft part sarcoma	0
cervical carcinosarcoma +	0
cervix carcinoma +	407
cervix endometrial stromal tumor +	0
cervix melanoma +	0
epithelioid trophoblastic tumor	0
Path 2
Term	Annotations
disease	199753
disease of anatomical entity	168001
Urogenital Diseases	48628
Female Urogenital Diseases and Pregnancy Complications	23741
Female Urogenital Diseases	19468
female reproductive system disease	19438
uterine disease	5036
Uterine Neoplasms	4561
uterine cancer	3088
cervical cancer	924
cervical alveolar soft part sarcoma	0
cervical carcinosarcoma +	0
cervix carcinoma +	407
cervix endometrial stromal tumor +	0
cervix melanoma +	0
epithelioid trophoblastic tumor	0

paths to the root